Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	antigen binding	IGHV3-48 IGHV3-43 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 IGHV3-43D IGHV3-64D IGHV3-30-5 IGHV3-30-3 IGHV3-38-3 IGHV3-74 IGHV3-72	1.35e-16	190	144	19	GO:0003823
GeneOntologyMolecularFunction	histone binding	ATRX KDM5A HJURP RSF1 MCM3AP BRD9 PRKCB CDYL KDM4A	1.33e-04	265	144	9	GO:0042393
GeneOntologyBiologicalProcess	immunoglobulin mediated immune response	IGHV3-48 IGHV3-43 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 IGHV3-43D IGHV3-64D RIF1 IGHV3-30-5 IGHV3-30-3 IGHV3-38-3 IGHV3-74 IGHV3-72	3.95e-16	235	147	20	GO:0016064
GeneOntologyBiologicalProcess	B cell mediated immunity	IGHV3-48 IGHV3-43 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 IGHV3-43D IGHV3-64D RIF1 IGHV3-30-5 IGHV3-30-3 IGHV3-38-3 IGHV3-74 IGHV3-72	8.19e-16	244	147	20	GO:0019724
GeneOntologyBiologicalProcess	lymphocyte mediated immunity	IGHV3-48 IGHV3-43 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 IGHV3-43D STAT5B IGHV3-64D RIF1 IGHV3-30-5 IGHV3-30-3 IGHV3-38-3 IGHV3-74 IGHV3-72	8.92e-12	449	147	21	GO:0002449
GeneOntologyBiologicalProcess	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	IGHV3-48 IGHV3-43 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 IGHV3-43D IGHV3-64D RIF1 NLRP10 IGHV3-30-5 IGHV3-30-3 IGHV3-38-3 IGHV3-74 IGHV3-72	1.52e-11	462	147	21	GO:0002460
GeneOntologyBiologicalProcess	leukocyte mediated immunity	IGHV3-48 IGHV3-43 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 IGHV3-43D STAT5B IGHV3-64D RIF1 IGHV3-30-5 IGHV3-30-3 IGHV3-38-3 IGHV3-74 IGHV3-72	8.71e-10	576	147	21	GO:0002443
GeneOntologyBiologicalProcess	adaptive immune response	IGHV3-48 IGHV3-43 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 IGHV3-43D IGHV3-64D RIF1 NLRP10 TRBV11-3 TRBV11-2 TRBV11-1 IGHV3-30-5 IGHV3-30-3 PRKCB IGHV3-38-3 IGHV3-74 IGHV3-72	1.19e-09	838	147	25	GO:0002250
GeneOntologyBiologicalProcess	immune effector process	IGHV3-48 IGHV3-43 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 SRC IGHV3-43D STAT5B IGHV3-64D RIF1 IGHV3-30-5 PLCL2 IGHV3-30-3 IGHV3-38-3 IGHV3-74 IGHV3-72	4.39e-08	859	147	23	GO:0002252
GeneOntologyBiologicalProcess	mRNA processing	METTL3 SRSF4 RBMXL1 DDX42 CWC22 NSRP1 SCAF1 SAFB RBMXL2 PRPF3 LUC7L2 RBMX SLTM USP39 IK CLP1 PCBP4 THRAP3	8.13e-08	551	147	18	GO:0006397
GeneOntologyBiologicalProcess	regulation of mRNA processing	SRSF4 RBMXL1 CWC22 NSRP1 SAFB RBMXL2 RBMX SLTM PCBP4 THRAP3	2.02e-07	158	147	10	GO:0050684
GeneOntologyBiologicalProcess	mRNA splicing, via spliceosome	METTL3 SRSF4 RBMXL1 DDX42 CWC22 NSRP1 RBMXL2 PRPF3 LUC7L2 RBMX USP39 IK PCBP4 THRAP3	2.90e-07	358	147	14	GO:0000398
GeneOntologyBiologicalProcess	RNA splicing, via transesterification reactions with bulged adenosine as nucleophile	METTL3 SRSF4 RBMXL1 DDX42 CWC22 NSRP1 RBMXL2 PRPF3 LUC7L2 RBMX USP39 IK PCBP4 THRAP3	2.90e-07	358	147	14	GO:0000377
GeneOntologyBiologicalProcess	RNA splicing, via transesterification reactions	METTL3 SRSF4 RBMXL1 DDX42 CWC22 NSRP1 RBMXL2 PRPF3 LUC7L2 RBMX USP39 IK PCBP4 THRAP3	3.32e-07	362	147	14	GO:0000375
GeneOntologyBiologicalProcess	RNA splicing	METTL3 SRSF4 RBMXL1 DDX42 CWC22 NSRP1 SCAF1 RBMXL2 PRPF3 LUC7L2 RBMX USP39 IK CLP1 PCBP4 THRAP3	6.22e-07	502	147	16	GO:0008380
GeneOntologyBiologicalProcess	regulation of mRNA splicing, via spliceosome	SRSF4 RBMXL1 CWC22 NSRP1 RBMXL2 RBMX PCBP4 THRAP3	4.05e-06	129	147	8	GO:0048024
GeneOntologyBiologicalProcess	chromatin organization	METTL3 ATRX KDM5A HJURP RSF1 BCOR MSL2 RIF1 BRD8 SAFB MCM3AP SETBP1 MDC1 BRD9 PRKCB CDYL KDM4A DNMT3B ZNF445	2.11e-05	896	147	19	GO:0006325
GeneOntologyBiologicalProcess	chromatin remodeling	METTL3 ATRX KDM5A HJURP RSF1 BCOR MSL2 RIF1 MCM3AP SETBP1 BRD9 PRKCB CDYL KDM4A DNMT3B ZNF445	8.01e-05	741	147	16	GO:0006338
GeneOntologyBiologicalProcess	protein-DNA complex organization	METTL3 ATRX KDM5A HJURP RSF1 BCOR MSL2 RIF1 BRD8 SAFB MCM3AP SETBP1 MDC1 BRD9 PRKCB CDYL KDM4A DNMT3B ZNF445	9.10e-05	999	147	19	GO:0071824
GeneOntologyBiologicalProcess	mRNA metabolic process	METTL3 SRSF4 RBMXL1 DDX42 CWC22 NSRP1 SCAF1 SAFB RBMXL2 PRPF3 LUC7L2 RBMX SLTM USP39 IK CLP1 PCBP4 THRAP3	9.52e-05	917	147	18	GO:0016071
GeneOntologyBiologicalProcess	regulation of RNA splicing	SRSF4 RBMXL1 CWC22 NSRP1 RBMXL2 RBMX PCBP4 THRAP3	1.22e-04	207	147	8	GO:0043484
GeneOntologyBiologicalProcess	positive regulation of mRNA splicing, via spliceosome	RBMXL1 RBMXL2 RBMX THRAP3	2.69e-04	44	147	4	GO:0048026
GeneOntologyBiologicalProcess	regulation of mRNA metabolic process	METTL3 SRSF4 RBMXL1 CWC22 NSRP1 SAFB RBMXL2 RBMX SLTM PCBP4 THRAP3	3.42e-04	443	147	11	GO:1903311
GeneOntologyBiologicalProcess	positive regulation of mRNA processing	RBMXL1 RBMXL2 RBMX THRAP3	4.09e-04	49	147	4	GO:0050685
GeneOntologyCellularComponent	immunoglobulin complex	IGHV3-48 IGHV3-43 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 IGHV3-43D IGHV3-64D IGHV3-30-5 IGHV3-30-3 IGHV3-38-3 IGHV3-74 IGHV3-72	5.18e-18	166	145	19	GO:0019814
GeneOntologyCellularComponent	nuclear protein-containing complex	ELOA ERCC5 RBMXL1 RSF1 DDX42 EXOSC1 BCL9 BCOR CWC22 STAT5B BRD8 RBMXL2 PRPF3 LUC7L2 ASXL3 RBMX MCM3AP BRD9 POLR1B HAND1 USP39 IK CLP1 THRAP3 MED13 EPB41L2	2.70e-06	1377	145	26	GO:0140513
GeneOntologyCellularComponent	spliceosomal complex	RBMXL1 DDX42 CWC22 RBMXL2 PRPF3 LUC7L2 RBMX USP39 IK	1.97e-05	215	145	9	GO:0005681
GeneOntologyCellularComponent	spectrin	SPTBN2 PRKCB EPB41L2	2.66e-05	9	145	3	GO:0008091
GeneOntologyCellularComponent	striated muscle myosin thick filament	TRIM32 MYBPC3	2.84e-04	4	145	2	GO:0005863
GeneOntologyCellularComponent	supraspliceosomal complex	RBMXL1 RBMX	2.84e-04	4	145	2	GO:0044530
GeneOntologyCellularComponent	nuclear body	METTL3 SRSF4 ATRX DDX42 CWC22 NSRP1 EIF2D PRPF3 LUC7L2 SCN1A SETBP1 MDC1 SLTM CDYL IK THRAP3	5.43e-04	903	145	16	GO:0016604
GeneOntologyCellularComponent	U2-type spliceosomal complex	DDX42 CWC22 PRPF3 LUC7L2 IK	5.79e-04	97	145	5	GO:0005684
GeneOntologyCellularComponent	myosin filament	MYH8 TRIM32 MYBPC3	6.72e-04	25	145	3	GO:0032982
GeneOntologyCellularComponent	nuclear speck	METTL3 SRSF4 DDX42 CWC22 NSRP1 PRPF3 LUC7L2 CDYL IK THRAP3	8.70e-04	431	145	10	GO:0016607
Domain	RBM1CTR	RBMXL1 RBMXL2 RBMX	1.52e-05	8	123	3	PF08081
Domain	RBM1CTR	RBMXL1 RBMXL2 RBMX	1.52e-05	8	123	3	IPR012604
Domain	ZF_PHD_2	ATRX KDM5A RSF1 PHF3 ASXL3 KDM4A	3.89e-05	95	123	6	PS50016
Domain	ZF_PHD_1	ATRX KDM5A RSF1 PHF3 ASXL3 KDM4A	4.12e-05	96	123	6	PS01359
Domain	-	CWC22 EIF4G1 BZW1	1.20e-04	15	123	3	1.25.40.180
Domain	MIF4-like	CWC22 EIF4G1 BZW1	1.20e-04	15	123	3	IPR016021
Domain	XPG_CS	ERCC5 FEN1	1.29e-04	3	123	2	IPR019974
Domain	XPG_I	ERCC5 FEN1	2.56e-04	4	123	2	PF00867
Domain	XPG-I_dom	ERCC5 FEN1	2.56e-04	4	123	2	IPR006086
Domain	XPG/Rad2	ERCC5 FEN1	2.56e-04	4	123	2	IPR006084
Domain	HhH2	ERCC5 FEN1	2.56e-04	4	123	2	IPR008918
Domain	ADD	ATRX DNMT3B	2.56e-04	4	123	2	IPR025766
Domain	5-3_exonuclease_C	ERCC5 FEN1	2.56e-04	4	123	2	IPR020045
Domain	XPG_1	ERCC5 FEN1	2.56e-04	4	123	2	PS00841
Domain	XPG_2	ERCC5 FEN1	2.56e-04	4	123	2	PS00842
Domain	ADD	ATRX DNMT3B	2.56e-04	4	123	2	PS51533
Domain	HhH2	ERCC5 FEN1	2.56e-04	4	123	2	SM00279
Domain	XPGN	ERCC5 FEN1	2.56e-04	4	123	2	SM00485
Domain	XPGI	ERCC5 FEN1	2.56e-04	4	123	2	SM00484
Domain	XPG_DNA_repair_N	ERCC5 FEN1	4.25e-04	5	123	2	IPR006085
Domain	XPG_N	ERCC5 FEN1	4.25e-04	5	123	2	PF00752
Domain	Znf_FYVE_PHD	ATRX KDM5A RSF1 PHF3 KDM4A DNMT3B	4.28e-04	147	123	6	IPR011011
Domain	RRM_1	RBMXL1 RBMXL2 RBMX	4.48e-04	23	123	3	SM00361
Domain	RRM_dom_euk	RBMXL1 RBMXL2 RBMX	4.48e-04	23	123	3	IPR003954
Domain	MA3	CWC22 EIF4G1	6.34e-04	6	123	2	SM00544
Domain	MA3	CWC22 EIF4G1	6.34e-04	6	123	2	PF02847
Domain	Initiation_fac_eIF4g_MI	CWC22 EIF4G1	6.34e-04	6	123	2	IPR003891
Domain	MI	CWC22 EIF4G1	6.34e-04	6	123	2	PS51366
Domain	FHA	KIF1B CEP170 MDC1	8.10e-04	28	123	3	SM00240
Domain	eIF5C	EIF4G1 BZW1	8.84e-04	7	123	2	SM00515
Domain	W2	EIF4G1 BZW1	8.84e-04	7	123	2	PF02020
Domain	W2	EIF4G1 BZW1	8.84e-04	7	123	2	PS51363
Domain	W2_domain	EIF4G1 BZW1	8.84e-04	7	123	2	IPR003307
Domain	FHA_DOMAIN	KIF1B CEP170 MDC1	1.09e-03	31	123	3	PS50006
Domain	FHA	KIF1B CEP170 MDC1	1.09e-03	31	123	3	PF00498
Domain	Nucleotide-bd_a/b_plait	SRSF4 RBMXL1 SAFB RBMXL2 RBMX MCM3AP SLTM	1.61e-03	258	123	7	IPR012677
Domain	-	KIF1B CEP170 MDC1	1.70e-03	36	123	3	2.60.200.20
Domain	FHA_dom	KIF1B CEP170 MDC1	1.70e-03	36	123	3	IPR000253
Domain	MIF4G	CWC22 EIF4G1	1.87e-03	10	123	2	SM00543
Domain	JmjN	KDM5A KDM4A	1.87e-03	10	123	2	SM00545
Domain	MIF4G	CWC22 EIF4G1	1.87e-03	10	123	2	PF02854
Domain	JmjN	KDM5A KDM4A	1.87e-03	10	123	2	PF02375
Domain	MIF4G-like_typ-3	CWC22 EIF4G1	1.87e-03	10	123	2	IPR003890
Domain	JMJN	KDM5A KDM4A	1.87e-03	10	123	2	PS51183
Domain	JmjN	KDM5A KDM4A	1.87e-03	10	123	2	IPR003349
Domain	Ephrin_rec_like	TG SCUBE2	2.28e-03	11	123	2	PF07699
Domain	RRM_1	SRSF4 RBMXL1 SAFB RBMXL2 RBMX SLTM	2.56e-03	208	123	6	PF00076
Domain	-	ERCC5 FEN1	2.72e-03	12	123	2	3.40.50.1010
Domain	PHD	KDM5A RSF1 PHF3 KDM4A	2.84e-03	89	123	4	SM00249
Domain	-	ATRX KDM5A RSF1 MSL2 TRIM32 PHF3 KDM4A USP39 DNMT3B	2.91e-03	449	123	9	3.30.40.10
Domain	Znf_PHD	KDM5A RSF1 PHF3 KDM4A	3.08e-03	91	123	4	IPR001965
Domain	RRM	SRSF4 RBMXL1 SAFB RBMXL2 RBMX SLTM	3.16e-03	217	123	6	SM00360
Domain	Znf_RING/FYVE/PHD	ATRX KDM5A RSF1 MSL2 TRIM32 PHF3 KDM4A USP39 DNMT3B	3.37e-03	459	123	9	IPR013083
Domain	PIN_domain-like	ERCC5 FEN1	3.72e-03	14	123	2	IPR029060
Domain	RRM_dom	SRSF4 RBMXL1 SAFB RBMXL2 RBMX SLTM	3.94e-03	227	123	6	IPR000504
Domain	RRM	SRSF4 RBMXL1 SAFB RBMXL2 RBMX SLTM	4.20e-03	230	123	6	PS50102
Domain	SMAD_FHA_domain	KIF1B CEP170 MDC1	4.87e-03	52	123	3	IPR008984
Domain	-	SRSF4 RBMXL1 SAFB RBMXL2 RBMX SLTM	5.58e-03	244	123	6	3.30.70.330
Domain	AGC-kinase_C	MAST2 PRKCB PRKG1	5.99e-03	56	123	3	IPR000961
Domain	AGC_KINASE_CTER	MAST2 PRKCB PRKG1	5.99e-03	56	123	3	PS51285
Domain	S_TK_X	MAST2 PRKCB PRKG1	5.99e-03	56	123	3	SM00133
Pathway	REACTOME_CD22_MEDIATED_BCR_REGULATION	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 IGHV3-64D IGHV3-74	1.40e-15	35	110	11	MM17219
Pathway	REACTOME_FCGR_ACTIVATION	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 SRC IGHV3-64D IGHV3-74	1.52e-15	48	110	12	MM17214
Pathway	REACTOME_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 IGHV3-64D IGHV3-74	5.47e-15	39	110	11	MM17212
Pathway	REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 IGHV3-64D IGHV3-74	3.19e-14	45	110	11	MM14912
Pathway	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 IGHV3-64D IGHV3-74	2.27e-13	53	110	11	MM15716
Pathway	REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 IGHV3-64D IGHV3-74	2.83e-13	54	110	11	MM14655
Pathway	REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 IGHV3-64D IGHV3-74	4.35e-13	56	110	11	MM14815
Pathway	REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 IGHV3-64D IGHV3-74	6.57e-13	58	110	11	MM14914
Pathway	REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 IGHV3-64D IGHV3-74	9.76e-13	60	110	11	MM14872
Pathway	REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 IGHV3-64D IGHV3-74	9.76e-13	60	110	11	MM14913
Pathway	REACTOME_COMPLEMENT_CASCADE	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 IGHV3-64D IGHV3-74	4.53e-11	84	110	11	MM14653
Pathway	REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 SRC IGHV3-64D IGHV3-74	7.86e-11	114	110	12	MM14814
Pathway	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 SRC IGHV3-64D PROC IGHV3-74	2.78e-10	158	110	13	MM14812
Pathway	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 IGHV3-64D PRKCB IGHV3-74	4.05e-10	131	110	12	MM15717
Pathway	REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 IGHV3-64D IGHV3-74	6.51e-10	107	110	11	MM14915
Pathway	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 IGHV3-64D IGHV3-74	7.84e-09	135	110	11	MM14781
Pathway	REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 IGHV3-64D IGHV3-74	2.37e-08	150	110	11	MM14889
Pathway	REACTOME_HEMOSTASIS	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 PDE9A IGHV3-11 IGHV3-7 KIF26B KIF1B SRC IGHV3-64D PRKCB PRKG1 PROC IGHV3-74	4.08e-07	571	110	18	MM14472
Pathway	REACTOME_FCGR_ACTIVATION	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7 SRC	1.05e-06	69	110	7	M27108
Pathway	REACTOME_VESICLE_MEDIATED_TRANSPORT	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 KIF26B GJB6 KIF1B SPTBN2 SRC DENND2B IGHV3-64D SNX18 IGHV3-74	2.35e-06	645	110	18	MM15232
Pathway	REACTOME_CD22_MEDIATED_BCR_REGULATION	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7	7.71e-06	61	110	6	M27581
Pathway	REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7 SRC	9.13e-06	95	110	7	M29842
Pathway	REACTOME_ADAPTIVE_IMMUNE_SYSTEM	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 SPTBN2 SRC IGHV3-64D CCNF TRIM32 PRKCB PRKG1 HERC1 IGHV3-74	1.06e-05	719	110	18	MM14540
Pathway	REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7	1.58e-05	69	110	6	M27150
Pathway	REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7	1.87e-05	71	110	6	M1078
Pathway	REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7	1.87e-05	71	110	6	M27203
Pathway	REACTOME_PARASITE_INFECTION	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7 SRC	3.37e-05	116	110	7	M29843
Pathway	REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7	3.70e-05	80	110	6	M6121
Pathway	REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7	4.26e-05	82	110	6	M27110
Pathway	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7	5.57e-05	86	110	6	M601
Pathway	REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7	5.57e-05	86	110	6	M27206
Pathway	REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7	5.95e-05	87	110	6	M27205
Pathway	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA	METTL3 SRSF4 DDX42 CWC22 NSRP1 PRPF3 RBMX USP39 IK CLP1	7.26e-05	283	110	10	M13087
Pathway	REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7 SRC	8.45e-05	134	110	7	M29840
Pathway	REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7	1.16e-04	98	110	6	M27152
Pathway	REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7 SRC	1.27e-04	143	110	7	M27107
Pathway	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7 SRC PROC	1.38e-04	194	110	8	M16312
Pathway	REACTOME_HEMOSTASIS	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 PDE9A IGHV3-11 IGHV3-7 WEE1 KIF26B KIF1B SRC ITGA10 PRKCB PRKG1 PROC	2.48e-04	679	110	15	M8395
Pathway	REACTOME_MRNA_SPLICING	SRSF4 DDX42 CWC22 NSRP1 PRPF3 RBMX USP39 IK	2.53e-04	212	110	8	M14033
Pathway	REACTOME_COMPLEMENT_CASCADE	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7	2.78e-04	115	110	6	M19752
Pathway	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA	METTL3 DDX42 CWC22 NSRP1 PRPF3 RBMX USP39 IK CLP1	3.15e-04	277	110	9	MM15414
Pathway	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7 PRKCB	3.19e-04	166	110	7	M608
Pathway	REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7	6.80e-04	136	110	6	M27207
Pathway	WP_MRNA_PROCESSING	METTL3 SRSF4 RBMXL1 EIF2D RBMXL2 PRPF3 RBMX SLTM CLP1 PCBP4 RPL19	7.86e-04	451	110	11	MM15946
Pathway	REACTOME_METABOLISM_OF_RNA	METTL3 DDX42 EXOSC1 CWC22 NSRP1 PRPF3 RBMX EIF4G1 USP39 IK CLP1 UTP14C RPL19	9.49e-04	612	110	13	MM15547
Pathway	REACTOME_MRNA_SPLICING	DDX42 CWC22 NSRP1 PRPF3 RBMX USP39 IK	9.95e-04	201	110	7	MM15411
Pathway	REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7	1.30e-03	154	110	6	M39007
Pathway	REACTOME_METABOLISM_OF_RNA	METTL3 SRSF4 DDX42 EXOSC1 CWC22 NSRP1 PRPF3 RBMX EIF4G1 USP39 IK CLP1 UTP14C RPL19	1.48e-03	724	110	14	M16843
Pathway	REACTOME_LEISHMANIA_INFECTION	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-11 IGHV3-7 SRC	1.63e-03	219	110	7	M29836
Pubmed	1.3 A X-ray structure of an antibody Fv fragment used for induced membrane-protein crystallization.	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 IGHV3-64D IGHV3-74	8.89e-24	15	150	11	12657787
Pubmed	Early onset of somatic mutation in immunoglobulin VH genes during the primary immune response.	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 IGHV3-64D IGHV3-74	4.48e-21	22	150	11	2499654
Pubmed	IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes.	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7 IGHV3-64D IGHV3-74 IGHV3-72	1.52e-17	77	150	13	15608191
Pubmed	The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus.	IGHV3-48 IGHV3-43 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 IGHV3-74 IGHV3-72	1.51e-16	91	150	13	9841928
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	ELOA IGHV3-30 SRSF4 MAP1A RBMXL1 KDM5A SPTBN2 DDX42 CWC22 NSRP1 CEP170 SAFB PRPF3 TRIM32 LUC7L2 RBMX EIF4G1 FEN1 SLTM USP39 IK CLP1 THRAP3 UNC13A IGHV3-72 DNMT3B	1.16e-12	1082	150	26	38697112
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ELOA SRSF4 ATRX RSF1 DDX42 BCOR SRFBP1 CWC22 NSRP1 CEP170 RIF1 BRD8 SAFB PRPF3 PHF3 RBMX MDC1 EIF4G1 FEN1 BRD9 SLTM ANKRD11 IK THRAP3	3.64e-12	954	150	24	36373674
Pubmed	Structure and physical map of 64 variable segments in the 3'0.8-megabase region of the human immunoglobulin heavy-chain locus.	IGHV3-48 IGHV3-43 IGHV3-38 IGHV3-23 IGHV3-20 IGHV3-11 IGHV3-9 IGHV3-7	5.45e-12	39	150	8	8490662
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	SRSF4 ATRX KDM5A DDX42 EXOSC1 DHX33 PRC1 BCOR SRFBP1 MSL2 SCAF1 RIF1 BRD8 SAFB PRPF3 PHF3 LUC7L2 RBMX MDC1 SLTM ANKRD11 CDYL USP39 IK THRAP3 CDCA7L RPL19	1.04e-11	1294	150	27	30804502
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ELOA ERCC5 ATRX KDM5A WEE1 KIF1B BCL9 BCOR SCAF1 RIF1 EIF2D BRD8 SAFB RBMXL2 PHF3 RBMX MDC1 EIF4G1 THRAP3 MED13 EPB41L2	2.30e-11	774	150	21	15302935
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	SRSF4 PPP1R12A DDX42 EXOSC1 MPRIP RIF1 SAFB PRPF3 PHF3 LUC7L2 RBMX MDC1 EIF4G1 FEN1 SLTM POLR1B USP39 IK THRAP3 CDCA7L RPL19	1.20e-10	847	150	21	35850772
Pubmed	HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137.	ELOA ATRX DDX42 SAFB PRPF3 RBMX MDC1 FEN1 SLTM THRAP3	1.01e-09	148	150	10	32538781
Pubmed	Molecular analysis of spontaneous somatic mutants.	IGHV3-48 IGHV3-21 IGHV3-11 IGHV3-7	1.66e-09	5	150	4	401950
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	ELOA METTL3 ATRX RSF1 DDX42 PRC1 RIF1 BRD8 SAFB PRPF3 PHF3 MDC1 EIF4G1 BRD9 SLTM BZW1 USP39 IK THRAP3 CDCA7L MED13	3.00e-09	1014	150	21	32416067
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	ELOA METTL3 RBMXL1 PPP1R12A SPTBN2 PRC1 CWC22 MPRIP CEP170 SAFB PRPF3 PHF3 RBMX MDC1 EIF4G1 FEN1 SLTM POLR1B USP39 IK THRAP3 EPB41L2 RPL19	5.14e-09	1257	150	23	36526897
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	METTL3 SRSF4 ATRX DDX42 RIF1 EIF2D BRD8 PRPF3 LUC7L2 RBMX FEN1 BZW1 USP39 IK CLP1 THRAP3	5.36e-09	582	150	16	20467437
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	RBMXL1 PPP1R12A SPTBN2 DHX33 PRC1 DENND2B NSRP1 MPRIP SAFB PRPF3 LUC7L2 RBMX MDC1 FEN1 BRD9 SLTM POLR1B IK THRAP3 RPL19	5.52e-09	949	150	20	36574265
Pubmed	KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4.	ELOA DDX42 SRFBP1 NSRP1 SAFB PRPF3 IK CLP1 THRAP3	5.73e-09	130	150	9	35545047
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	METTL3 ATRX KDM5A PPP1R12A EXOSC1 DHX33 BCOR SRFBP1 MPRIP MSL2 SCAF1 RIF1 BRD8 TRIM32 PHF3 MDC1 EIF4G1 BRD9 ANKRD11 POLR1B CDYL IK CLP1 MED13 EPB41L2	6.38e-09	1497	150	25	31527615
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	SRC MAST2 CEP170 SCAF1 SAFB PHF3 ASXL3 RBMX MDC1 EIF4G1 SLTM USP39 THRAP3	6.67e-09	361	150	13	26167880
Pubmed	RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.	ELOA SRSF4 RBMXL1 SPTBN2 EXOSC1 MPRIP CEP170 SAFB PRPF3 RBMX EIF4G1 SLTM USP39 IK THRAP3 IGHV3-72 RPL19	1.42e-08	713	150	17	29802200
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	SRSF4 PPP1R12A DDX42 PRC1 CWC22 MPRIP SAFB PRPF3 RBMX MDC1 EIF4G1 POLR1B USP39 IK THRAP3 EPB41L2	3.09e-08	660	150	16	32780723
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	METTL3 RSF1 PRC1 NSRP1 STAT5B RIF1 BRD8 SAFB PHF3 RBMX EIF4G1 BZW1 THRAP3 EPB41L2	4.36e-08	503	150	14	16964243
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	ELOA ATRX DDX42 SRFBP1 RIF1 PRPF3 PHF3 MDC1 FEN1 IK THRAP3	4.67e-08	283	150	11	30585729
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	ATRX PITRM1 DDX42 RTN3 PRC1 MAST2 CWC22 STX12 SCAF1 RIF1 SAFB LUC7L2 RBMX MDC1 EIF4G1 FEN1 SLTM BZW1 USP39 IK THRAP3 EPB41L2 RPL19	5.15e-08	1425	150	23	30948266
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	ELOA DDX42 DHX33 PRC1 SRFBP1 CWC22 NSRP1 SCAF1 RIF1 SAFB PHF3 LUC7L2 RBMX MDC1 SLTM USP39 IK THRAP3 RPL19	5.89e-08	989	150	19	36424410
Pubmed	Characterizing ZC3H18, a Multi-domain Protein at the Interface of RNA Production and Destruction Decisions.	SRSF4 RBMXL1 SPTBN2 EXOSC1 PRC1 SRFBP1 CWC22 SAFB PRPF3 LUC7L2 RBMX SLTM USP39 IK THRAP3 RPL19	1.24e-07	731	150	16	29298432
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	SRSF4 RBMXL1 RSF1 CWC22 SCAF1 SAFB PRPF3 USP39 IK THRAP3	1.55e-07	251	150	10	31076518
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	SRSF4 SPTBN2 RSF1 DDX42 CEP170 RIF1 PHF3 RBMX MCM3AP MDC1 EIF4G1 SLTM IK EPB41L2 RPL19	1.70e-07	653	150	15	22586326
Pubmed	The interactome of CLUH reveals its association to SPAG5 and its co-translational proximity to mitochondrial proteins.	SRSF4 PITRM1 CWC22 SAFB LUC7L2 EIF4G1 SLTM BZW1 THRAP3	2.69e-07	203	150	9	35012549
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	DDX42 BCL9 BCOR BRD8 PRPF3 PHF3 MDC1 IK CLP1 MED13	2.83e-07	268	150	10	33640491
Pubmed	SAFB1, an RBMX-binding protein, is a newly identified regulator of hepatic SREBP-1c gene.	RBMXL1 SAFB RBMX	3.14e-07	4	150	3	19403048
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	PEX1 ATP8B2 NSRP1 MPRIP RIF1 BRD8 PRPF3 PHF3 MDC1 FEN1 IK THRAP3 RPL19	3.36e-07	506	150	13	30890647
Pubmed	mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.	SRSF4 PPP1R12A SPTBN2 MPRIP CEP170 SAFB PRPF3 EIF4G1 IK THRAP3	3.47e-07	274	150	10	34244482
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ELOA ATRX MAP1A PPP1R12A RSF1 DDX42 BCOR NSRP1 MPRIP CEP170 RIF1 SAFB PRPF3 FEN1 PLSCR3 EPB41L2 RPL19	6.51e-07	934	150	17	33916271
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	SRSF4 ATRX WEE1 PPP1R12A KIF1B MAST2 TCEAL1 MPRIP EIF2D PRPF3 PTPRS LUC7L2 RBMX EIF4G1 PIP5K1B BZW1 USP39 HERC1 THRAP3 EPB41L2	7.27e-07	1284	150	20	17353931
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	WEE1 HJURP PEX1 DYNC2I1 BCOR MAST2 TRIM32 RBMX THRAP3	8.22e-07	232	150	9	25515538
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	SRSF4 PPP1R12A BCOR MAST2 MPRIP MDC1 HERC1 THRAP3 UTP14C	8.83e-07	234	150	9	36243803
Pubmed	Heavy chain variable region contribution to the NPb family of antibodies: somatic mutation evident in a gamma 2a variable region.	IGHV3-48 IGHV3-21 IGHV3-11 IGHV3-7	9.70e-07	18	150	4	6788376
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	KDM5A WEE1 KIF26B PPP1R12A KIF1B HJURP MAST2 DENND2B MPRIP CEP170 NHSL1 C2CD3 PHF3 EIF4G1 ANKRD11 EPB41L2	1.08e-06	861	150	16	36931259
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	ELOA MYH8 ATRX PITRM1 KDM5A WEE1 EXOSC1 MSL2 TLNRD1 SCAF1 EIF2D BRD8 SAFB MCM3AP EIF4G1 SLTM ANKRD11 KDM4A BZW1 MED13	1.21e-06	1327	150	20	32694731
Pubmed	Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair.	RBMXL1 PEX1 PRC1 CAVIN4 EIF2D RBMX SNX18 MED13 UTP14C RPL19	1.46e-06	321	150	10	32098917
Pubmed	The ubiquitin ligase Uhrf2 is a master regulator of cholesterol biosynthesis and is essential for liver regeneration.	ATRX RSF1 RIF1 PHF3 THRAP3 UTP14C	2.06e-06	86	150	6	37253089
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	MYH8 ERCC5 REC114 ATRX WEE1 PPP1R12A SRC PEX1 ANKRD36C GPATCH2L MPRIP CEP170 EIF4G1 ANKRD36 PRKG1 THRAP3	2.21e-06	910	150	16	36736316
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	SPTBN2 SRC DDX42 CEP170 SCAF1 RIF1 SAFB PRPF3 RBMX MDC1 EIF4G1 SLTM USP39 IK THRAP3 EPB41L2 RPL19	2.27e-06	1024	150	17	24711643
Pubmed	ATG5 is required for B cell polarization and presentation of particulate antigens.	PPP1R12A DDX42 EXOSC1 PRC1 CWC22 NSRP1 MPRIP CEP170 EIF2D SAFB RBMX BRD9 SLTM IK	2.31e-06	701	150	14	30196744
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	SRSF4 PPP1R12A DDX42 PRC1 SRFBP1 FAM13B NSRP1 MPRIP CEP170 RIF1 PRPF3 TRIM32 LUC7L2 FEN1 USP39 EPB41L2	2.41e-06	916	150	16	32203420
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	ELOA ATRX KDM5A RSF1 BCOR RIF1 PHF3 MDC1 FEN1 BRD9 CDYL KDM4A USP39	2.58e-06	608	150	13	36089195
Pubmed	TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.	ELOA SRSF4 WEE1 PPP1R12A BCOR TCEAL1 MPRIP TLNRD1 EIF2D RBMX PLCL2 EIF4G1 ANKRD11 THRAP3 MED13 RPL19	2.62e-06	922	150	16	27609421
Pubmed	Complete haplotype sequence of the human immunoglobulin heavy-chain variable, diversity, and joining genes and characterization of allelic and copy-number variation.	IGHV3-43D IGHV3-64D IGHV3-38-3	2.72e-06	7	150	3	23541343
Pubmed	Activation of annexin 7 by protein kinase C in vitro and in vivo.	SRC PRKCB PRKG1	2.72e-06	7	150	3	11278415
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	MAP1A KDM5A PPP1R12A EXOSC1 PRC1 MPRIP CEP170 PHF3 EIF4G1 BRD9 SNX18 POLR1B IK THRAP3	3.36e-06	724	150	14	36232890
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	ATRX WEE1 PRC1 MPRIP CEP170 PRPF3 PHF3 MDC1 SNX18 POLR1B CLP1	3.62e-06	440	150	11	34244565
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	MAP1A DDX42 BCOR CEP170 SAFB PRPF3 PHF3 EIF4G1 SLTM IK EPB41L2	3.94e-06	444	150	11	34795231
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	ELOA MYH8 ERCC5 ATRX RBMXL1 KDM5A PPP1R12A SPTBN2 RSF1 DDX42 C2CD3 SAFB RBMXL2 RBMX EIF4G1 THRAP3 MED13 UTP14C DNMT3B RPL19	4.23e-06	1442	150	20	35575683
Pubmed	The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors.	ELOA SRC RTN3 TG CDYL MED13	4.69e-06	99	150	6	19730683
Pubmed	Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets.	WEE1 RSF1 RBMX MDC1 FEN1 HERC1 THRAP3	5.72e-06	157	150	7	30686591
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	RSF1 DHX33 MPRIP RIF1 EIF2D SAFB PRPF3 TRIM32 RBMX MCM3AP MDC1 EIF4G1 FEN1 SLTM POLR1B IK THRAP3 EPB41L2 RPL19	6.30e-06	1353	150	19	29467282
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	MAP1A KDM5A WEE1 PPP1R12A AOX1 RSF1 PEX1 BCOR MAST2 NSRP1 CEP170 SCAF1 BRD8 PRPF3 LUC7L2 MCM3AP BRD9	7.06e-06	1116	150	17	31753913
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	ATRX MAP1A RTN3 MPRIP PRKCB THRAP3 EPB41L2 RPL19	7.85e-06	231	150	8	16452087
Pubmed	Comparative architectural aspects of regions of conserved synteny on human chromosome 11p15.3 and mouse chromosome 7 (including genes WEE1 and LMO1).	WEE1 DENND2B SCUBE2	9.23e-06	10	150	3	11528126
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	WEE1 PPP1R12A HJURP DDX42 DYNC2I1 PRC1 CWC22 MPRIP MSL2 CEP170 BRD8 PRPF3 RBMX EIF4G1 USP39 CLP1 THRAP3	1.10e-05	1155	150	17	20360068
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	PPP1R12A SPTBN2 MEI1 RYR3 IGHV3-64D LUC7L2 ANKRD11 KDM4A USP39 HERC1 IK	1.14e-05	497	150	11	36774506
Pubmed	Interactome analyses revealed that the U1 snRNP machinery overlaps extensively with the RNAP II machinery and contains multiple ALS/SMA-causative proteins.	SRSF4 DDX42 RIF1 SAFB RBMX SLTM IK THRAP3	1.17e-05	244	150	8	29884807
Pubmed	Transcription factor protein interactomes reveal genetic determinants in heart disease.	RSF1 MSL2 SAFB LUC7L2 BRD9 SLTM IK THRAP3 UTP14C DNMT3B	1.28e-05	411	150	10	35182466
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	ELOA DDX42 SAFB PRPF3 LUC7L2 RBMX MDC1 EIF4G1 USP39 IK THRAP3 RPL19	1.35e-05	605	150	12	28977666
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	IGHV3-15 MAP1A PPP1R12A KIF1B SPTBN2 RTN3 MPRIP CEP170 NHSL1 SAFB PTPRS RBMX EIF4G1 PRKCB THRAP3 UNC13A EPB41L2 IGHV3-72 RPL19	1.38e-05	1431	150	19	37142655
Pubmed	Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.	SRSF4 DDX42 CWC22 NSRP1 SAFB PRPF3 RBMX EIF4G1 FEN1 USP39 IK THRAP3 RPL19	1.44e-05	714	150	13	28302793
Pubmed	RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma.	PPP1R12A DDX42 EXOSC1 PRC1 SAFB PHF3 RPL19	1.55e-05	183	150	7	28186131
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	MAP1A BCOR CEP170 C2CD3 LUC7L2 RBMX MCM3AP	1.61e-05	184	150	7	32908313
Pubmed	Circular RNA circPVT1 promotes nasopharyngeal carcinoma metastasis via the β-TrCP/c-Myc/SRSF1 positive feedback loop.	CWC22 CEP170 SAFB TRIM32 RBMX EIF4G1 THRAP3 RPL19	1.85e-05	260	150	8	36199071
Pubmed	Protein kinase G type Ialpha activity in human ovarian cancer cells significantly contributes to enhanced Src activation and DNA synthesis/cell proliferation.	SRC PRKG1	1.85e-05	2	150	2	20371672
Pubmed	Differential effect of the overexpression of Rad2/XPG family endonucleases on genome integrity in yeast and human cells.	ERCC5 FEN1	1.85e-05	2	150	2	28704715
Pubmed	Variable region sequences of five human immunoglobulin heavy chains of the VH3 subgroup: definitive identification of four heavy chain hypervariable regions.	IGHV3-23 IGHV3-7	1.85e-05	2	150	2	4522793
Pubmed	p116Rip decreases myosin II phosphorylation by activating myosin light chain phosphatase and by inactivating RhoA.	PPP1R12A MPRIP	1.85e-05	2	150	2	15545284
Pubmed	Signal transduction pathways regulated by prolactin and Src result in different conformations of activated Stat5b.	SRC STAT5B	1.85e-05	2	150	2	12621061
Pubmed	METTL3-STAT5B interaction facilitates the co-transcriptional m6A modification of mRNA to promote breast tumorigenesis.	METTL3 STAT5B	1.85e-05	2	150	2	39218290
Pubmed	Interactions between the leucine-zipper motif of cGMP-dependent protein kinase and the C-terminal region of the targeting subunit of myosin light chain phosphatase.	PPP1R12A PRKG1	1.85e-05	2	150	2	17904578
Pubmed	Single nucleotide polymorphisms in the XPG gene: determination of role in DNA repair and breast cancer risk.	ERCC5 FEN1	1.85e-05	2	150	2	12494477
Pubmed	Novel domains in the hnRNP G/RBMX protein with distinct roles in RNA binding and targeting nascent transcripts.	RBMXL2 RBMX	1.85e-05	2	150	2	21327109
Pubmed	Sequence and expression of a novel human T-cell receptor beta-chain variable gene segment subfamily.	TRBV11-3 TRBV11-1	1.85e-05	2	150	2	2272661
Pubmed	Delineating the HMGB1 and HMGB2 interactome in prostate and ovary epithelial cells and its relationship with cancer.	ATRX RSF1 SAFB RBMX SLTM THRAP3 RPL19	1.85e-05	188	150	7	29721183
Pubmed	Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination.	KDM5A BRD8 SAFB RBMX BRD9	1.89e-05	75	150	5	25593309
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	MAP1A WEE1 HJURP ANKRD62 BCL9 TULP4 SCN1A SETBP1 MDC1 DNMT3B	1.89e-05	430	150	10	35044719
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	ERCC5 ATRX PPP1R12A HJURP DDX42 PEX1 BCOR GPATCH2L BRD8 RBMX PLCL2 SLTM HERC1 IK UTP14C ZNF445	1.96e-05	1084	150	16	11544199
Pubmed	A genome-wide in situ hybridization map of RNA-binding proteins reveals anatomically restricted expression in the developing mouse brain.	SRSF4 RBMXL1 SAFB RBMXL2 PRPF3 RBMX SLTM POLR1B PCBP4	2.14e-05	347	150	9	16033648
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	METTL3 ATRX RSF1 CWC22 RIF1 MDC1 BRD9 SNX18 CDYL USP39 EPB41L2	2.17e-05	533	150	11	30554943
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	SPTBN2 MAST2 MCM3AP PLCL2 UNC13A MED13	2.24e-05	130	150	6	12421765
Pubmed	Dynamic protein-protein interaction wiring of the human spliceosome.	SRSF4 DDX42 CWC22 NSRP1 PRPF3 RBMX IK	2.50e-05	197	150	7	22365833
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	ELOA HJURP DHX33 PRC1 CEP170 RIF1 PRPF3 PHF3 RBMX EIF4G1 POLR1B IK RPL19	2.72e-05	759	150	13	35915203
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	EXOSC1 RIF1 PHF3 EIF4G1 FEN1 SLTM IK CDCA7L UTP14C	3.52e-05	370	150	9	22922362
Pubmed	Comparative genomic sequencing reveals a strikingly similar architecture of a conserved syntenic region on human chromosome 11p15.3 (including gene ST5) and mouse chromosome 7.	WEE1 DENND2B SCUBE2	4.23e-05	16	150	3	11528127
Pubmed	Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1.	BCOR NSRP1 EIF4G1 BRD9 IK THRAP3 EPB41L2	4.36e-05	215	150	7	35973513
Pubmed	ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair.	RSF1 BRD8 RBMX MDC1 CDYL DNMT3B	5.00e-05	150	150	6	28242625
Pubmed	R2TP/Prefoldin-like component RUVBL1/RUVBL2 directly interacts with ZNHIT2 to regulate assembly of U5 small nuclear ribonucleoprotein.	SRSF4 CWC22 SCAF1 BRD8 PRPF3 LUC7L2 USP39 RPL19	5.09e-05	300	150	8	28561026
Pubmed	The protein interaction landscape of the human CMGC kinase group.	ERCC5 SRSF4 EXOSC1 DHX33 NSRP1 TCEAL1 PHF3 LUC7L2 RBMX USP39 THRAP3 MED13	5.18e-05	695	150	12	23602568
Pubmed	Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.	SRSF4 DHX33 CEP170 RBMXL2 PRPF3 LUC7L2 EIF4G1 FEN1 USP39 THRAP3	5.30e-05	486	150	10	30940648
Pubmed	Involvement of Src in the membrane skeletal complex, MPP6-4.1G, in Schmidt-Lanterman incisures of mouse myelinated nerve fibers in PNS.	SRC EPB41L2	5.53e-05	3	150	2	23306908
Pubmed	RBMX is a novel hepatic transcriptional regulator of SREBP-1c gene response to high-fructose diet.	RBMXL1 RBMX	5.53e-05	3	150	2	17188681
Pubmed	ST5 Positively Regulates Osteoclastogenesis via Src/Syk/calcium Signaling Pathways.	SRC DENND2B	5.53e-05	3	150	2	31707778
Pubmed	RBMY evolved on the Y chromosome from a ubiquitously transcribed X-Y identical gene.	RBMXL1 RBMX	5.53e-05	3	150	2	10391207
Interaction	DHX8 interactions	ELOA SRSF4 DDX42 PRC1 BCOR CWC22 NSRP1 SCAF1 SAFB PRPF3 LUC7L2 RBMX SLTM POLR1B IK THRAP3 RPL19	1.19e-11	292	135	17	int:DHX8
Interaction	SNRNP70 interactions	ELOA METTL3 SRSF4 PDE9A RBMXL1 PPP1R12A SPTBN2 EXOSC1 PRC1 CWC22 MPRIP CEP170 CCNF SCAF1 SAFB PRPF3 LUC7L2 RBMX EIF4G1 SLTM BZW1 USP39 IK THRAP3 EPB41L2 IGHV3-72 RPL19	3.29e-10	984	135	27	int:SNRNP70
Interaction	DDX23 interactions	ELOA SRSF4 DDX42 DHX33 PRC1 SRFBP1 CWC22 NSRP1 CCNF SCAF1 SAFB PRPF3 PHF3 RBMX SLTM ANKRD11 USP39 IK THRAP3	5.19e-10	480	135	19	int:DDX23
Interaction	MECP2 interactions	ELOA IGHV3-30 SRSF4 ATRX MAP1A RBMXL1 KDM5A SPTBN2 DDX42 PRC1 CWC22 NSRP1 CEP170 SAFB PRPF3 TRIM32 LUC7L2 RBMX EIF4G1 FEN1 SLTM USP39 IK CLP1 THRAP3 UNC13A EPB41L2 IGHV3-72 DNMT3B	6.06e-09	1287	135	29	int:MECP2
Interaction	DHX40 interactions	ELOA ERCC5 DHX33 NSRP1 SCAF1 BRD8 SAFB RBMX SLTM ANKRD11 HERC1 IK THRAP3	1.32e-08	249	135	13	int:DHX40
Interaction	PRC1 interactions	ATRX RBMXL1 PPP1R12A SPTBN2 RSF1 ITGA10 DHX33 PRC1 CWC22 SAFB RBMXL2 RBMX MDC1 BRD9 SLTM PLSCR3 USP39 HERC1 IK THRAP3 UNC13A EPB41L2 UTP14C RPL19	2.85e-08	973	135	24	int:PRC1
Interaction	H3C1 interactions	ELOA ATRX KDM5A RSF1 DDX42 PRC1 SRFBP1 NSRP1 RIF1 PRPF3 PHF3 LUC7L2 MDC1 EIF4G1 FEN1 PRKCB CDYL KDM4A USP39 IK THRAP3 DNMT3B RPL19	3.10e-08	901	135	23	int:H3C1
Interaction	SMC5 interactions	ELOA SRSF4 ATRX RSF1 DDX42 BCOR SRFBP1 CWC22 NSRP1 CEP170 RIF1 BRD8 SAFB PRPF3 PHF3 RBMX MDC1 EIF4G1 FEN1 BRD9 SLTM ANKRD11 IK THRAP3	4.78e-08	1000	135	24	int:SMC5
Interaction	YWHAG interactions	WEE1 KIF26B PPP1R12A KIF1B SRC HJURP RTN3 PRC1 MAST2 CWC22 FAM13B DENND2B MPRIP MSL2 CEP170 CCNF NHSL1 C2CD3 TRIM32 PHF3 LUC7L2 EIF4G1 ANKRD11 PRKCB ARL14EP THRAP3 EPB41L2	5.19e-08	1248	135	27	int:YWHAG
Interaction	GAGE5 interactions	ELOA RBMXL1 PPP1R12A NSRP1 MPRIP PHF3 SLTM	5.39e-08	52	135	7	int:GAGE5
Interaction	H2BC8 interactions	ELOA METTL3 ERCC5 ATRX RSF1 DDX42 PRC1 BCOR SRFBP1 NSRP1 RIF1 BRD8 PHF3 MDC1 FEN1 CDYL USP39 IK	5.91e-08	576	135	18	int:H2BC8
Interaction	CPSF6 interactions	METTL3 GIN1 DDX42 CWC22 NSRP1 CCNF SAFB PRPF3 PHF3 LUC7L2 RBMX MDC1 EIF4G1 SLTM USP39 CLP1 THRAP3	8.81e-08	526	135	17	int:CPSF6
Interaction	DOT1L interactions	SRSF4 ATRX PPP1R12A DDX42 EXOSC1 MPRIP RIF1 SAFB PRPF3 PHF3 LUC7L2 MDC1 EIF4G1 FEN1 SLTM POLR1B USP39 IK THRAP3 CDCA7L RPL19	9.64e-08	807	135	21	int:DOT1L
Interaction	SNRPA interactions	SRSF4 DDX42 PRC1 MAST2 CWC22 NSRP1 CCNF SAFB PRPF3 PHF3 RBMX SLTM BZW1 USP39 IK THRAP3	1.51e-07	482	135	16	int:SNRPA
Interaction	NUP43 interactions	ERCC5 KDM5A PPP1R12A RSF1 PRC1 BCOR CWC22 MSL2 SCAF1 RIF1 BRD8 SAFB LUC7L2 RBMX MCM3AP MDC1 EIF4G1 ANKRD11	2.00e-07	625	135	18	int:NUP43
Interaction	TOP1 interactions	METTL3 WEE1 RSF1 DDX42 PRC1 NSRP1 CCNF SCAF1 SAFB PRPF3 TRIM32 PHF3 ASXL3 RBMX FEN1 SLTM USP39 IK THRAP3	2.02e-07	696	135	19	int:TOP1
Interaction	CBX3 interactions	ELOA ATRX PPP1R12A RSF1 DDX42 PRC1 BCOR SRFBP1 NSRP1 CCNF RIF1 PRPF3 PHF3 MDC1 FEN1 CDYL PRKG1 DNMT3B	3.24e-07	646	135	18	int:CBX3
Interaction	UQCR11 interactions	RBMXL1 NSRP1 MPRIP RBMXL2 PHF3 SLTM	1.43e-06	53	135	6	int:UQCR11
Interaction	CSNK2A1 interactions	ERCC5 ATRX WEE1 KIF1B SRC RSF1 ANKRD36C BCOR GPATCH2L CEP170 EIF2D SAFB LUC7L2 ASXL3 RBMX MDC1 BRD9 ANKRD11 ANKRD36 THRAP3 EPB41L2	1.54e-06	956	135	21	int:CSNK2A1
Interaction	PEA15 interactions	ELOA RBMXL1 CEP170 SAFB LUC7L2 SLTM ANKRD11	2.44e-06	90	135	7	int:PEA15
Interaction	SSRP1 interactions	ELOA ATRX RSF1 DDX42 PRC1 SRFBP1 SCAF1 RIF1 SAFB PRPF3 PHF3 RBMX FEN1 SLTM ANKRD11 USP39 THRAP3	3.41e-06	685	135	17	int:SSRP1
Interaction	YWHAH interactions	KDM5A WEE1 KIF26B PPP1R12A KIF1B SRC HJURP MAST2 CWC22 DENND2B MPRIP CEP170 CCNF NHSL1 C2CD3 TRIM32 PHF3 EIF4G1 ANKRD11 ARL14EP HERC1 EPB41L2	4.00e-06	1102	135	22	int:YWHAH
Interaction	CHD4 interactions	ELOA PPP1R12A SRC RSF1 DDX42 PRC1 CWC22 CCNF SAFB PRPF3 LUC7L2 RBMX MDC1 EIF4G1 BZW1 USP39 IK THRAP3 DNMT3B RPL19	4.39e-06	938	135	20	int:CHD4
Interaction	IFI27L1 interactions	ELOA RBMXL1 NSRP1 SAFB SLTM IK	4.83e-06	65	135	6	int:IFI27L1
Interaction	SRSF7 interactions	SRSF4 RBMXL1 DYNC2I1 PRC1 CWC22 CCNF SCAF1 SAFB PRPF3 LUC7L2 USP39 IK THRAP3	5.79e-06	425	135	13	int:SRSF7
Interaction	SRSF1 interactions	SRSF4 RBMXL1 HJURP PRC1 CCNF SCAF1 LUC7L2 RBMX MDC1 KDM4A BZW1 USP39 IK THRAP3 RPL19	6.67e-06	570	135	15	int:SRSF1
Interaction	SNRPC interactions	SRSF4 RBMXL1 DDX42 PRC1 CWC22 NSRP1 SAFB PRPF3 PHF3 RBMX USP39 IK THRAP3	8.40e-06	440	135	13	int:SNRPC
Interaction	CSNK2A3 interactions	SRC ANKRD36C PRC1 GPATCH2L CEP170 ANKRD36 THRAP3	9.28e-06	110	135	7	int:CSNK2A3
Interaction	CIT interactions	RBMXL1 PPP1R12A SPTBN2 RSF1 DDX42 PRC1 SRFBP1 MPRIP CEP170 SCAF1 RIF1 SAFB RBMXL2 PRPF3 RBMX MDC1 EIF4G1 POLR1B CDYL USP39 HERC1 IK THRAP3 UTP14C RPL19	1.07e-05	1450	135	25	int:CIT
Interaction	GLDC interactions	SRSF4 PPP1R12A SPTBN2 MPRIP CEP170 CCNF SAFB PRPF3 EIF4G1 IK THRAP3	1.09e-05	321	135	11	int:GLDC
Interaction	RPA4 interactions	ERCC5 DDX42 PRC1 CEP170 RIF1 SAFB EIF4G1 FEN1 SLTM IK THRAP3 EPB41L2 RPL19	1.12e-05	452	135	13	int:RPA4
Interaction	PRP4K interactions	SRSF4 DDX42 PRC1 CWC22 NSRP1 PRPF3 LUC7L2 USP39 IK THRAP3 RPL19	1.37e-05	329	135	11	int:PRP4K
Interaction	NUPR1 interactions	SRSF4 PPP1R12A DDX42 PRC1 CWC22 MPRIP SAFB PRPF3 RBMX MDC1 EIF4G1 POLR1B USP39 IK THRAP3 EPB41L2	1.38e-05	683	135	16	int:NUPR1
Interaction	SRSF10 interactions	SRSF4 PRC1 LUC7L2 RBMX DSG4 BZW1 USP39 IK EPB41L2 RPL19	1.48e-05	271	135	10	int:SRSF10
Interaction	SFN interactions	SRSF4 MAP1A WEE1 KIF26B PPP1R12A KIF1B MAST2 DENND2B MPRIP CEP170 TRIM32 PHF3 LUC7L2 RBMX EIF4G1 EPB41L2	1.63e-05	692	135	16	int:SFN
Interaction	ACTC1 interactions	METTL3 PEX1 PRC1 ATP8B2 NSRP1 MPRIP RIF1 BRD8 PRPF3 PHF3 MDC1 FEN1 BRD9 IK THRAP3 RPL19	1.68e-05	694	135	16	int:ACTC1
Interaction	POLR2C interactions	ELOA KIF1B SRC CCNF SCAF1 PHF3 MDC1 POLR1B CLP1 MED13 DNMT3B	1.77e-05	338	135	11	int:POLR2C
Interaction	TNIP1 interactions	ELOA RBMXL1 PPP1R12A SPTBN2 DHX33 PRC1 DENND2B NSRP1 STX12 MPRIP SAFB PRPF3 LUC7L2 RBMX MDC1 FEN1 BRD9 SLTM POLR1B IK THRAP3 RPL19	1.90e-05	1217	135	22	int:TNIP1
Interaction	YWHAZ interactions	ELOA WEE1 KIF26B PPP1R12A KIF1B SPTBN2 HJURP RSF1 BCOR MAST2 FAM13B DENND2B MPRIP MSL2 CEP170 CCNF NHSL1 TRIM32 PHF3 ASXL3 MDC1 ARL14EP EPB41L2	2.13e-05	1319	135	23	int:YWHAZ
Interaction	ZC3H18 interactions	SRSF4 RBMXL1 SPTBN2 EXOSC1 PRC1 BCOR SRFBP1 CWC22 SAFB PRPF3 LUC7L2 RBMX SLTM USP39 IK THRAP3 EPB41L2 RPL19	2.30e-05	877	135	18	int:ZC3H18
Interaction	CDK12 interactions	ELOA SRSF4 ATRX WEE1 CWC22 GPATCH2L CCNF IK THRAP3	2.36e-05	228	135	9	int:CDK12
Interaction	VDR interactions	KDM5A SRC SNX18 ANKRD11 THRAP3 CDCA7L MED13	2.37e-05	127	135	7	int:VDR
Interaction	SNRNP40 interactions	RSF1 BCL9 PRC1 BCOR CWC22 CCNF SCAF1 PRPF3 RBMX MDC1 CDYL BZW1 USP39 IK EPB41L2	2.46e-05	637	135	15	int:SNRNP40
Interaction	SRPK2 interactions	SRSF4 SRC MAST2 NSRP1 CEP170 CCNF SCAF1 SAFB LUC7L2 RBMX MDC1 EIF4G1 SLTM USP39 THRAP3 EPB41L2	2.51e-05	717	135	16	int:SRPK2
Interaction	SAA1 interactions	RBMXL1 MPRIP SAFB PHF3 SLTM	3.04e-05	54	135	5	int:SAA1
Interaction	MFAP1 interactions	ATRX PITRM1 DDX42 NSRP1 CCNF PRPF3 EIF4G1 IK CDCA7L EPB41L2	3.05e-05	295	135	10	int:MFAP1
Interaction	EIF4A3 interactions	METTL3 SRSF4 PRC1 CWC22 CCNF PRPF3 RBMX MDC1 EIF4G1 IK THRAP3 CDCA7L RPL19	3.15e-05	499	135	13	int:EIF4A3
Interaction	CFAP141 interactions	ELOA MYH8 RBMXL1 NSRP1 SLTM	3.33e-05	55	135	5	int:CFAP141
Interaction	EPB41L2 interactions	DRD3 PPP1R12A DDX42 PRC1 CWC22 NSRP1 CCNF RBMX BRD9 EPB41L2	3.42e-05	299	135	10	int:EPB41L2
Interaction	SIRT7 interactions	SRSF4 SPTBN2 RSF1 DDX42 CEP170 RIF1 PHF3 RBMX MCM3AP MDC1 EIF4G1 SLTM USP39 IK EPB41L2 RPL19	3.91e-05	744	135	16	int:SIRT7
Interaction	H3-3A interactions	ELOA ATRX KDM5A RSF1 DYNC2I1 BCOR CCNF RIF1 PHF3 MDC1 FEN1 BRD9 CDYL KDM4A USP39 THRAP3	4.23e-05	749	135	16	int:H3-3A
Interaction	CDK1 interactions	WEE1 KIF26B PPP1R12A SRC HJURP RSF1 PRC1 CCNF SAFB RBMXL2 ASXL3 EIF4G1 FEN1 PRKCB	4.30e-05	590	135	14	int:CDK1
Interaction	LINC02910 interactions	ELOA RBMXL1 DYNC2I1 NSRP1 SAFB SLTM	4.31e-05	95	135	6	int:LINC02910
Interaction	PCBP1 interactions	METTL3 WEE1 KIF1B PRC1 MPRIP CCNF EIF2D PRPF3 PHF3 LUC7L2 ASXL3 EIF4G1 PCBP4 THRAP3 RPL19	4.47e-05	671	135	15	int:PCBP1
Interaction	YWHAB interactions	WEE1 KIF26B PPP1R12A KIF1B SRC HJURP RTN3 MAST2 DENND2B MPRIP CEP170 CCNF NHSL1 TRIM32 PHF3 RBMX EIF4G1 ARL14EP EPB41L2	4.66e-05	1014	135	19	int:YWHAB
Interaction	CHD3 interactions	ELOA HJURP DDX42 BCOR RIF1 SAFB PRPF3 PTPRS LUC7L2 RBMX EIF4G1 USP39 IK THRAP3 EPB41L2 RPL19	4.80e-05	757	135	16	int:CHD3
Interaction	MEN1 interactions	SRSF4 ATRX DDX42 EXOSC1 RIF1 SAFB PRPF3 RBMX MCM3AP SETBP1 MDC1 EIF4G1 SLTM POLR1B USP39 IK THRAP3 CDCA7L RPL19	5.67e-05	1029	135	19	int:MEN1
Interaction	KIF23 interactions	IGHV3-33 IGHV3-23 RBMXL1 PPP1R12A RSF1 PRC1 MAST2 MPRIP TG CEP170 CCNF C2CD3 SAFB RBMXL2 TRIM32 RBMX EIF4G1 THRAP3 RPL19	5.82e-05	1031	135	19	int:KIF23
Interaction	RAD18 interactions	ELOA SRSF4 RBMXL1 RSF1 CWC22 SCAF1 SAFB PRPF3 USP39 IK THRAP3 EPB41L2	5.97e-05	457	135	12	int:RAD18
Interaction	H2BC12 interactions	METTL3 ATRX CCNF SCAF1 PHF3 ASXL3 SLTM ANKRD11 PRKCB ANKRD36	6.37e-05	322	135	10	int:H2BC12
Interaction	TPX2 interactions	RBMXL1 PRC1 NSRP1 CCDC85A MPRIP PHF3 MDC1 SLTM	7.10e-05	204	135	8	int:TPX2
Interaction	KIF20A interactions	RBMXL1 PPP1R12A SPTBN2 PRC1 MPRIP CEP170 CCNF SAFB RBMXL2 TRIM32 RBMX MDC1 PIP5K1B POLR1B CDYL HERC1 IK THRAP3 RPL19	7.61e-05	1052	135	19	int:KIF20A
Interaction	PPP1CB interactions	RBMXL1 PPP1R12A SPTBN2 PRC1 DENND2B MPRIP CCNF RIF1 SAFB RBMX PLCL2 EIF4G1	7.64e-05	469	135	12	int:PPP1CB
Interaction	SF3A1 interactions	DDX42 PRC1 NSRP1 CCNF PRPF3 LUC7L2 ASXL3 RBMX MDC1 EIF4G1 USP39 THRAP3	7.95e-05	471	135	12	int:SF3A1
Interaction	SIRT6 interactions	METTL3 ATRX WEE1 DYNC2I1 PRC1 BCOR MPRIP CEP170 PRPF3 PHF3 MDC1 SNX18 POLR1B CLP1	8.38e-05	628	135	14	int:SIRT6
Interaction	TERF2IP interactions	ELOA METTL3 ERCC5 RSF1 DDX42 BCOR NSRP1 RIF1 BRD8 PHF3 MDC1 ANKRD11 IK	8.80e-05	552	135	13	int:TERF2IP
Interaction	ANKRD50 interactions	RBMXL1 PPP1R12A NSRP1 MPRIP PHF3 SLTM	8.84e-05	108	135	6	int:ANKRD50
Interaction	RPS19 interactions	SRSF4 GIN1 PPP1R12A HJURP DDX42 PRC1 NSRP1 CCNF ASXL3 EIF4G1 BZW1 THRAP3 EPB41L2 RPL19	1.01e-04	639	135	14	int:RPS19
Interaction	PIP4K2A interactions	ELOA DDX42 CWC22 NSRP1 CCDC85A PRPF3 LUC7L2 SLTM	1.06e-04	216	135	8	int:PIP4K2A
Interaction	DRD3 interactions	DRD3 PRKCB DSG4 EPB41L2	1.07e-04	37	135	4	int:DRD3
Interaction	AR interactions	ATRX SRC DDX42 BCL9 BCOR BRD8 NLRP10 PRPF3 TRIM32 PHF3 MDC1 FEN1 KDM4A PRKG1 IK CLP1 THRAP3 MED13	1.13e-04	992	135	18	int:AR
Interaction	CLK1 interactions	ERCC5 SRSF4 PDE9A SAFB PHF3 ASXL3 RBMX THRAP3	1.16e-04	219	135	8	int:CLK1
Interaction	SNIP1 interactions	SRSF4 RBMXL1 DDX42 CWC22 NSRP1 SCAF1 PRPF3 LUC7L2 IK THRAP3 EPB41L2	1.17e-04	417	135	11	int:SNIP1
Interaction	U2AF2 interactions	METTL3 SRSF4 DDX42 PRC1 CCNF SCAF1 SAFB PRPF3 LUC7L2 RBMX EIF4G1 BZW1 IK THRAP3	1.22e-04	651	135	14	int:U2AF2
Interaction	RBBP4 interactions	KDM5A HJURP PRC1 BCOR STAT5B CCNF SAFB LUC7L2 ASXL3 CDYL BZW1 THRAP3 DNMT3B	1.28e-04	573	135	13	int:RBBP4
Interaction	POLR2H interactions	ELOA SRC CCNF SCAF1 POLR1B PRKG1 MED13 DNMT3B	1.32e-04	223	135	8	int:POLR2H
Interaction	TMSB4Y interactions	RBMXL1 MPRIP PHF3 SLTM	1.32e-04	39	135	4	int:TMSB4Y
Interaction	RBMXL2 interactions	RBMXL1 PRC1 RBMXL2 RBMX	1.46e-04	40	135	4	int:RBMXL2
Interaction	RECQL interactions	PPP1R12A DDX42 EXOSC1 PRC1 SAFB PHF3 MDC1 FEN1 RPL19	1.46e-04	289	135	9	int:RECQL
Interaction	SRSF2 interactions	METTL3 SRSF4 PRC1 CWC22 CCNF PRPF3 RBMX PRKCB BZW1	1.50e-04	290	135	9	int:SRSF2
Interaction	BRD2 interactions	METTL3 KDM5A RSF1 PRC1 CEP170 RIF1 PRPF3 MDC1 BRD9 SNX18 USP39	1.51e-04	429	135	11	int:BRD2
Interaction	PYHIN1 interactions	SRSF4 ATRX RSF1 SCAF1 SAFB PRPF3 PHF3 MDC1 DSG4 RPL19	1.52e-04	358	135	10	int:PYHIN1
Interaction	XRCC6 interactions	ELOA METTL3 ATRX DDX42 PRC1 SRFBP1 CCNF CAVIN4 RIF1 PRPF3 PHF3 ASXL3 MDC1 FEN1 IK THRAP3 RPL19	1.58e-04	928	135	17	int:XRCC6
Interaction	ZBTB7B interactions	PEX1 PRC1 CAVIN4 EIF2D RBMX SNX18 BZW1 THRAP3 MED13 RPL19	1.82e-04	366	135	10	int:ZBTB7B
Interaction	SNRPB interactions	METTL3 SRSF4 DDX42 PRC1 SAFB PRPF3 PHF3 RBMX MDC1 USP39 IK THRAP3	1.90e-04	517	135	12	int:SNRPB
Interaction	NUDT21 interactions	METTL3 DDX42 NSRP1 CCNF RIF1 LUC7L2 ASXL3 RBMX MDC1 CLP1	1.94e-04	369	135	10	int:NUDT21
Interaction	CDC5L interactions	ERCC5 SRSF4 DDX42 PRC1 CWC22 CCNF RIF1 EIF2D BRD8 PRPF3 RBMX MDC1 FEN1 BZW1 USP39 IK	1.97e-04	855	135	16	int:CDC5L
Interaction	RNF138 interactions	PPP1R12A CCDC85A MPRIP CCNF BZW1 PCBP4	1.97e-04	125	135	6	int:RNF138
Interaction	H2AZ1 interactions	WEE1 RSF1 PRC1 BCOR RIF1 BRD8 PRKCB CDYL KDM4A THRAP3	2.03e-04	371	135	10	int:H2AZ1
Interaction	POLR2B interactions	ELOA METTL3 SRC CCNF SCAF1 MDC1 SLTM POLR1B MED13 EPB41L2	2.03e-04	371	135	10	int:POLR2B
Interaction	PNN interactions	SRSF4 PRC1 CWC22 SCAF1 LUC7L2 MCM3AP BRD9 THRAP3 EPB41L2	2.03e-04	302	135	9	int:PNN
Interaction	LRPAP1 interactions	ELOA DDX42 NSRP1 PRPF3 LUC7L2 SLTM EPB41L2	2.14e-04	180	135	7	int:LRPAP1
Interaction	BTRC interactions	WEE1 MAST2 CWC22 MPRIP CEP170 CCNF SAFB RBMXL2 TRIM32 LUC7L2 SCN1A RBMX EIF4G1 THRAP3 RPL19	2.20e-04	775	135	15	int:BTRC
Interaction	SETDB2 interactions	DSG4 ARL14EP ZNF445	2.23e-04	18	135	3	int:SETDB2
Interaction	ANAPC15 interactions	ELOA RBMXL1 NSRP1 SAFB PHF3 SLTM	2.25e-04	128	135	6	int:ANAPC15
Interaction	H2BC21 interactions	ATRX RSF1 BCOR MSL2 CCNF RIF1 C2CD3 PHF3 MDC1 FEN1 PRKCB CDYL CDCA7L RPL19	2.44e-04	696	135	14	int:H2BC21
Interaction	YWHAE interactions	ELOA SRSF4 PITRM1 KIF26B PPP1R12A KIF1B SRC HJURP PRC1 MAST2 FAM13B DENND2B MPRIP MSL2 CEP170 CCNF TRIM32 PRKCB ARL14EP EPB41L2	2.65e-04	1256	135	20	int:YWHAE
Interaction	RBMX interactions	SRSF4 RBMXL1 PRC1 CCNF SAFB RBMXL2 ASXL3 RBMX BZW1 THRAP3 EPB41L2	2.80e-04	461	135	11	int:RBMX
Interaction	FBXO22 interactions	PPP1R12A SPTBN2 MEI1 RYR3 IGHV3-64D CCNF LUC7L2 ANKRD11 KDM4A USP39 HERC1 IK	2.83e-04	540	135	12	int:FBXO22
Interaction	SART1 interactions	ELOA SRSF4 DDX42 PRC1 NSRP1 PRPF3 USP39 THRAP3 DNMT3B	2.91e-04	317	135	9	int:SART1
Cytoband	14q32.33	IGHV3-48 IGHV3-43 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 IGHV3-30-5 IGHV3-30-3 IGHV3-38-3 IGHV3-74 IGHV3-72	2.00e-18	228	149	17	14q32.33
Cytoband	Ensembl 112 genes in cytogenetic band chr14q32	IGHV3-48 IGHV3-43 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7 IGHV3-64D IGHV3-74 IGHV3-72	5.67e-09	566	149	14	chr14q32
GeneFamily	Immunoglobulin heavy locus at 14q32.33	IGHV3-48 IGHV3-43 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 IGHV3-43D IGHV3-30-5 IGHV3-30-3 IGHV3-38-3 IGHV3-74 IGHV3-72	5.42e-18	187	96	18	349
GeneFamily	RNA binding motif containing	SRSF4 RBMXL1 SAFB RBMXL2 RBMX SLTM	9.57e-04	213	96	6	725
GeneFamily	Ankyrin repeat domain containing	PPP1R12A ANKRD62 ANKRD36C BCOR ANKRD11 ANKRD36	1.84e-03	242	96	6	403
Coexpression	XU_CREBBP_TARGETS_DN	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 IGHV3-64D IGHV3-74	9.62e-15	56	142	11	MM642
Coexpression	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 IGHV3-64D IGHV3-74	9.32e-12	102	142	11	MM872
Coexpression	RASHI_RESPONSE_TO_IONIZING_RADIATION_6	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 IGHV3-64D IGHV3-74	1.58e-10	132	142	11	MM996
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	ATRX KDM5A WEE1 PPP1R12A CEP170 RIF1 BRD8 PHF3 MDC1 CDYL	5.83e-06	300	142	10	M8702
Coexpression	GSE3982_BASOPHIL_VS_TH1_UP	KDM5A RTN3 FAM13B STAT5B BRD8 PRPF3 PRKCB IK	1.35e-05	199	142	8	M5564
Coexpression	MATTIOLI_MGUS_VS_PCL	IGHV3-33 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-7 IGHV3-72	6.87e-05	127	142	6	M10973
Coexpression	SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_DN	IGHV3-48 IGHV3-7 IGHV3-74	8.28e-05	16	142	3	M41742
Coexpression	FAELT_B_CLL_WITH_VH3_21_UP	IGHV3-23 SRC SAFB EIF4G1	1.04e-04	45	142	4	M15164
Coexpression	GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_UP	MAP1A HJURP LCT MAST2 CCNF SETBP1 DNMT3B	1.06e-04	198	142	7	M8041
Coexpression	GSE3982_DC_VS_BASOPHIL_DN	ERCC5 SRSF4 KDM5A PEX1 BRD8 PRPF3 PIP5K1B	1.10e-04	199	142	7	M5473
Coexpression	GSE14308_TH17_VS_INDUCED_TREG_DN	HJURP EXOSC1 MSL2 RBMXL2 TLL2 MDC1 PIP5K1B	1.13e-04	200	142	7	M3386
Coexpression	GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_DN	MAP1A HJURP LCT MAST2 CCNF SETBP1 DNMT3B	1.13e-04	200	142	7	M8039
Coexpression	GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN	PPP1R12A DDX42 ATP8B2 RIF1 NLRP10 MDC1 EPB41L2	1.13e-04	200	142	7	M7505
CoexpressionAtlas	AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500_k-means-cluster#2	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 IGHV3-74	1.07e-07	163	137	10	Arv_SC-hpx_blastocyst_500_K2
CoexpressionAtlas	AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500_k-means-cluster#3	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 IGHV3-74	2.08e-07	175	137	10	Arv_SC-H9hpx_500_K3
CoexpressionAtlas	AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000_k-means-cluster#5	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-9 IGHV3-7 IGHV3-74 IGHV3-72	3.15e-07	183	137	10	Arv_SC_fibroblast_1000_K5
CoexpressionAtlas	AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000_k-means-cluster#3	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-9 IGHV3-7 IGHV3-74 IGHV3-72	3.15e-07	183	137	10	Arv_SC-HD_1000_K3
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500	ATRX KIF1B HJURP RBMX EIF4G1 ANKRD11 HERC1 EPB41L2 ZNF445	5.72e-07	150	137	9	gudmap_developingGonad_e12.5_epididymis_k5_500
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000	ATRX KIF1B HJURP LYSMD3 CEP170 BRD8 RBMX EIF4G1 PRKG1 HERC1 EPB41L2 ZNF445	1.27e-06	323	137	12	gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000
CoexpressionAtlas	AravindRamakr_StemCell-HD_top-relative-expression-ranked_500_k-means-cluster#2	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-7 IGHV3-72	1.62e-06	126	137	8	Arv_SC-HD_500_K2
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000	ATRX KIF1B HJURP LYSMD3 BRD8 RBMX EIF4G1 ANKRD11 PRKG1 EPB41L2 ZNF445	1.89e-06	277	137	11	gudmap_developingGonad_e12.5_ovary_k3_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500	ATRX HJURP LYSMD3 RIF1 LUC7L2 ASXL3 RBMX EIF4G1 ANKRD11 PRKG1 HERC1 EPB41L2 ZNF445	2.85e-06	413	137	13	gudmap_developingGonad_e14.5_ epididymis_500
CoexpressionAtlas	AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500_k-means-cluster#3	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-7 IGHV3-72	3.38e-06	139	137	8	Arv_SC_fibroblast_500_K3
CoexpressionAtlas	AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_1000_k-means-cluster#4	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 IGHV3-74	4.27e-06	244	137	10	Arv_SC-H9hpx_1000_K4
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000	ATRX KIF1B HJURP LYSMD3 CEP170 RIF1 BRD8 LUC7L2 ASXL3 RBMX EIF4G1 KDM4A PRKG1 BZW1 HERC1 PCBP4 EPB41L2 ZNF445	5.23e-06	815	137	18	gudmap_developingGonad_e11.5_ovary + mesonephros_1000
CoexpressionAtlas	AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000_k-means-cluster#2	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 IGHV3-74	9.13e-06	266	137	10	Arv_SC-hpx_blastocyst_1000_K2
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000	ATRX KIF1B HJURP LYSMD3 RBMX EIF4G1 ANKRD11 EPB41L2 ZNF445	9.16e-06	210	137	9	gudmap_developingGonad_e18.5_ovary_1000_k2
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500	ATRX HJURP LYSMD3 RBMX EIF4G1 ANKRD11 EPB41L2 ZNF445	1.05e-05	162	137	8	gudmap_developingGonad_e16.5_epididymis_500_k2
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500	ATRX KIF1B HJURP RIF1 LUC7L2 ASXL3 RBMX EIF4G1 ANKRD11 HERC1 EPB41L2 ZNF445	1.22e-05	403	137	12	gudmap_developingGonad_e12.5_epididymis_500
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500	ATRX HJURP LYSMD3 LUC7L2 ASXL3 RBMX EIF4G1 ANKRD11 PRKG1 HERC1 EPB41L2 ZNF445	1.31e-05	406	137	12	gudmap_developingGonad_e16.5_epididymis_500
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000	ATRX KIF1B HJURP DDX42 LYSMD3 RIF1 TULP4 LUC7L2 ASXL3 RBMX EIF4G1 ANKRD11 PRKG1 HERC1 THRAP3 EPB41L2 ZNF445	1.37e-05	790	137	17	gudmap_developingGonad_e16.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000	ATRX KIF1B HJURP DDX42 LYSMD3 RBMX EIF4G1 ANKRD11 EPB41L2 ZNF445	1.47e-05	281	137	10	gudmap_developingGonad_e18.5_epididymis_1000_k3
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500	ATRX KIF1B HJURP LYSMD3 RBMX EIF4G1 PRKG1 ZNF445	1.62e-05	172	137	8	gudmap_developingGonad_e11.5_ovary + mesonephros_k4_500
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000	ATRX KIF1B HJURP DDX42 LYSMD3 RIF1 TULP4 LUC7L2 ASXL3 RBMX EIF4G1 ANKRD11 PRKG1 HERC1 THRAP3 EPB41L2 ZNF445	1.63e-05	801	137	17	gudmap_developingGonad_e14.5_ epididymis_1000
CoexpressionAtlas	AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 UCMA UNC13A IGHV3-74 DNMT3B	1.86e-05	492	137	13	Arv_SC-H9hpx_500
CoexpressionAtlas	AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 UCMA UNC13A IGHV3-74 DNMT3B	1.86e-05	492	137	13	Arv_SC-hpx_blastocyst_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000	KIF1B BCL9 STAT5B C2CD3 TULP4 PTPRS PHF3 ASXL3 EIF4G1 PRKG1 MED13	4.15e-05	385	137	11	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000	ATRX KIF1B HJURP LYSMD3 RBMX EIF4G1 ANKRD11 EPB41L2 ZNF445	4.79e-05	259	137	9	gudmap_developingGonad_e12.5_epididymis_k3_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5	PDE9A ATRX KDM5A WEE1 PPP1R12A DYNC2I1 RTN3 SRFBP1 NSRP1 CEP170 RIF1 SLTM USP39 ZNF445	5.76e-05	629	137	14	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000	ATRX KIF1B HJURP DDX42 LYSMD3 RIF1 LUC7L2 ASXL3 RBMX EIF4G1 ANKRD11 PRKG1 HERC1 THRAP3 EPB41L2 ZNF445	5.89e-05	799	137	16	gudmap_developingGonad_e18.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000	ATRX KIF1B HJURP LYSMD3 RIF1 BRD8 LUC7L2 ASXL3 RBMX EIF4G1 ANKRD11 PRKG1 HERC1 THRAP3 EPB41L2 ZNF445	6.34e-05	804	137	16	gudmap_developingGonad_e12.5_ovary_1000
CoexpressionAtlas	DevelopingKidney_e11.5_metaneph mesench_emap-3843_k-means-cluster#4_top-relative-expression-ranked_500	HJURP BCL9 TLNRD1 ANKRD11 PCBP4	8.38e-05	69	137	5	gudmap_developingKidney_e11.5_metaneph mesench_500_k4
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500	ATRX KIF1B HJURP LYSMD3 RIF1 LUC7L2 ASXL3 RBMX EIF4G1 PRKG1 ZNF445	8.49e-05	417	137	11	gudmap_developingGonad_e11.5_ovary + mesonephros_500
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000	KIF1B HJURP DDX42 LYSMD3 RBMX EIF4G1 ANKRD11 EPB41L2 ZNF445	9.72e-05	284	137	9	gudmap_developingGonad_e16.5_epididymis_1000_k2
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_200	ATRX HJURP LUC7L2 RBMX EIF4G1 PRKG1 EPB41L2	1.03e-04	166	137	7	gudmap_developingGonad_e16.5_epididymis_200
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_200	ATRX HJURP LYSMD3 LUC7L2 RBMX EIF4G1 EPB41L2	1.07e-04	167	137	7	gudmap_developingGonad_e14.5_ epididymis_200
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3	ATRX KIF26B PPP1R12A DYNC2I1 BCL9 NSRP1 UCMA MSL2 TLNRD1 RIF1 SLTM	1.16e-04	432	137	11	Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000	ATRX HJURP LYSMD3 RBMX EIF4G1 ANKRD11 EPB41L2 ZNF445	1.26e-04	230	137	8	gudmap_developingGonad_e16.5_ovary_1000_k2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	SRSF4 ATRX KDM5A WEE1 PPP1R12A RTN3 LYSMD3 NSRP1 MPRIP CEP170 MDC1 USP39 ZNF445	1.29e-04	595	137	13	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_200	ATRX HJURP RBMX EIF4G1 EPB41L2	1.33e-04	76	137	5	gudmap_developingGonad_e16.5_epididymis_200_k4
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_500	HJURP LYSMD3 RBMX EIF4G1 ANKRD11 PRKG1 ZNF445	1.43e-04	175	137	7	gudmap_developingGonad_e14.5_ epididymis_500_k4
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000	ATRX KDM5A KIF1B HJURP LYSMD3 RIF1 SCUBE2 TULP4 LUC7L2 RBMX EIF4G1 ANKRD11 HERC1 EPB41L2 ZNF445	1.54e-04	778	137	15	gudmap_developingGonad_e18.5_ovary_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_100	ATRX HJURP LUC7L2 EIF4G1 EPB41L2	2.13e-04	84	137	5	gudmap_developingGonad_e14.5_ epididymis_100
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000	ATRX HJURP LYSMD3 RBMX EIF4G1 ANKRD11 EPB41L2 ZNF445	2.18e-04	249	137	8	gudmap_developingGonad_P2_epididymis_1000_k3
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000	ATRX KIF1B HJURP RSF1 LYSMD3 RIF1 LUC7L2 ASXL3 RBMX EIF4G1 ANKRD11 HERC1 THRAP3 EPB41L2 ZNF445	2.26e-04	806	137	15	gudmap_developingGonad_e12.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_100	ATRX HJURP LUC7L2 EIF4G1 PRKG1	2.38e-04	86	137	5	gudmap_developingGonad_e16.5_epididymis_100
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#2_top-relative-expression-ranked_500	ATRX HJURP LYSMD3 EIF4G1 EPB41L2 ZNF445	2.56e-04	136	137	6	gudmap_developingGonad_P2_epididymis_500_k2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000	ATRX KIF1B RSF1 STAT5B RIF1 PHF3 ASXL3 PRKG1 MED13	2.98e-04	330	137	9	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500	ATRX HJURP LYSMD3 LUC7L2 RBMX EIF4G1 PRKG1 HERC1 EPB41L2 ZNF445	2.99e-04	404	137	10	gudmap_developingGonad_e18.5_epididymis_500
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#5_top-relative-expression-ranked_200	HJURP LYSMD3 RBMX EIF4G1 EPB41L2	3.10e-04	91	137	5	gudmap_developingGonad_e14.5_ epididymis_200_k5
CoexpressionAtlas	dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#1_top-relative-expression-ranked_1000	SPTBN2 EXOSC1 DHX33 PRC1 SRFBP1 CCNF RIF1 POLR1B CLP1	3.25e-04	334	137	9	gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k1_1000
CoexpressionAtlas	AravindRamakr_StemCell-HD_top-relative-expression-ranked_500	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-7 UCMA UNC13A IGHV3-72 DNMT3B	3.37e-04	489	137	11	Arv_SC-HD_500
CoexpressionAtlas	AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-7 UCMA UNC13A IGHV3-72 DNMT3B	3.37e-04	489	137	11	Arv_SC_fibroblast_500
CoexpressionAtlas	DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000	ATRX KDM5A HJURP RIF1 C2CD3 RBMX ANKRD11 MED13 DNMT3B	3.63e-04	339	137	9	gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5
CoexpressionAtlas	alpha beta T cells, preT.DN2.Th, Lin-/lo CD25hi CD44+ cKit+, Thymus, avg-3	DRC7 WEE1 PRC1 CCNF FEN1 PIP5K1B POLR1B PLSCR3 CDCA7L DNMT3B	4.06e-04	420	137	10	GSM791136_500
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000	ATRX KIF1B DDX42 TULP4 EIF4G1 ANKRD11 HERC1 EPB41L2	4.23e-04	275	137	8	gudmap_developingGonad_e14.5_ epididymis_1000_k3
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_500	HJURP LYSMD3 RBMX EIF4G1 EPB41L2 ZNF445	4.64e-04	152	137	6	gudmap_developingGonad_e18.5_epididymis_500_k4
CoexpressionAtlas	DevelopingKidney_e11.5_metaneph mesench_emap-3843_top-relative-expression-ranked_500	KIF26B HJURP BCL9 CCNF TLNRD1 TULP4 ASXL3 ANKRD11 PCBP4 DNMT3B	4.96e-04	431	137	10	gudmap_developingKidney_e11.5_metaneph mesench_500
CoexpressionAtlas	DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000	ATRX KIF26B EXOSC1 PEX1 BCL9 RIF1 C2CD3 BRD8 FEN1 PIP5K1B POLR1B ARL14EP PCBP4 MED13	5.21e-04	779	137	14	gudmap_developingKidney_e15.5_Cap mesenchyme_1000
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_200	ATRX HJURP RIF1 LUC7L2 EIF4G1 EPB41L2	5.88e-04	159	137	6	gudmap_developingGonad_e12.5_epididymis_200
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_200	ATRX HJURP EIF4G1 EPB41L2	6.51e-04	61	137	4	gudmap_developingGonad_e12.5_epididymis_k2_200
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000	MYH8 ATRX HJURP LYSMD3 RIF1 LUC7L2 RBMX EIF4G1 ANKRD11 PRKG1 HERC1 THRAP3 EPB41L2 ZNF445	6.52e-04	797	137	14	gudmap_developingGonad_P2_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000	ATRX KIF1B HJURP LYSMD3 RBMX EIF4G1 EPB41L2	6.56e-04	225	137	7	gudmap_developingGonad_e14.5_ ovary_1000_k3
CoexpressionAtlas	DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_200	MYH8 PPP1R12A LCT RYR3 SCUBE2 PRKCB	6.92e-04	164	137	6	gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_200
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_500	ATRX HJURP EIF4G1 EPB41L2 ZNF445	7.09e-04	109	137	5	gudmap_developingGonad_e16.5_ovary_500_k5
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_200	ATRX HJURP LUC7L2 EIF4G1 PRKG1 EPB41L2	7.37e-04	166	137	6	gudmap_developingGonad_e18.5_epididymis_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000	KIF26B PPP1R12A KIF1B BCL9 RYR3 STAT5B C2CD3 TULP4 PTPRS PHF3 ASXL3 EIF4G1 PRKG1 MED13	8.39e-04	818	137	14	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500	MYH8 REC114 ATRX KDM5A RIF1 LUC7L2 EIF4G1 HERC1 EPB41L2	8.52e-04	382	137	9	gudmap_developingGonad_e14.5_ ovary_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#2_top-relative-expression-ranked_500	MYH8 PPP1R12A LCT RYR3 PRKCB	9.04e-04	115	137	5	gudmap_developingLowerUrinaryTract_P1_bladder_B_500_k2
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_500	MYH8 ATRX HJURP RIF1 LUC7L2 EIF4G1 HERC1 EPB41L2 ZNF445	9.34e-04	387	137	9	gudmap_developingGonad_e16.5_ovary_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	PDE9A ATRX GIN1 NSRP1 RIF1 SAFB SETBP1 SLTM	9.45e-04	311	137	8	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#1_top-relative-expression-ranked_1000	MYH8 MAP1A BCL9 CWC22 PTPRS ASXL3 PRKG1	9.57e-04	240	137	7	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k1_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000	HJURP RSF1 STAT5B TULP4 PHF3 EIF4G1 CDYL PRKG1 MED13	1.12e-03	397	137	9	gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5
CoexpressionAtlas	DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#3_top-relative-expression-ranked_1000	EXOSC1 BCL9 FEN1 PIP5K1B POLR1B PCBP4	1.15e-03	181	137	6	gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k3
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	ATRX MAP1A KIF1B SPTBN2 RSF1 PEX1 DYNC2I1 RTN3 BCL9 PRC1 BCOR CWC22 CCDC85A PHF3 RBMX SETBP1 SLTM PRKCB THRAP3	1.29e-03	1370	137	19	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#4_top-relative-expression-ranked_100	MYH8 LCT RYR3	1.36e-03	34	137	3	gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_100_k4
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_1000	ATRX HJURP LYSMD3 RBMX PRKG1 THRAP3 ZNF445	1.39e-03	256	137	7	gudmap_developingGonad_e14.5_ epididymis_1000_k4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500	ATRX MAP1A RTN3 CWC22 NSRP1 RIF1 SAFB SCUBE2 SLTM CDCA7L	1.48e-03	498	137	10	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000	MYH8 REC114 ATRX KDM5A KIF1B HJURP LYSMD3 RIF1 LUC7L2 RBMX EIF4G1 HERC1 EPB41L2	1.56e-03	776	137	13	gudmap_developingGonad_e14.5_ ovary_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3	ATRX RTN3 NSRP1 RIF1 SAFB SLTM	1.56e-03	192	137	6	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	ELOA PDE9A ATRX GIN1 DYNC2I1 WDR27 MAST2 NSRP1 BRD9 KDM4A ARL14EP IK UTP14C	1.63e-03	780	137	13	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
CoexpressionAtlas	AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_2500_k-means-cluster#4	IGHV3-48 IGHV3-33 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 IGHV3-74	1.81e-03	426	137	9	Arv_SC-hpx_blastocyst_2500_K4
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_1000	MAP1A BCL9 DENND2B PTPRS ASXL3 PRKG1	1.87e-03	199	137	6	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_1000
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-48 IGHV3-43 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7 HJURP MEI1 IGHV3-74 IGHV3-72	1.24e-16	194	146	15	6ef4aeb8d8e35e4df58ff2a8256caa2113291de9
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7 MEI1 IGHV3-64D IGHV3-74 IGHV3-72	2.62e-15	190	146	14	79ee6d10dfbb775da149a1104da5823cf63bbb46
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7 MEI1 IGHV3-64D IGHV3-74 IGHV3-72	2.62e-15	190	146	14	18762ce78ed0b206ade19e1c8ff76a2647489f68
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-48 IGHV3-43 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7 MEI1 IGHV3-74 IGHV3-72	3.26e-15	193	146	14	34f6c13884fdf7f8a87f942fcb36a58cfac3f65d
ToppCell	COVID_vent-Lymphocytic-Plasma_cell-IgM_Plasmablast\|COVID_vent / Disease condition, Lineage, Cell class and subclass	IGHV3-48 IGHV3-43 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 IGHV3-74 IGHV3-72	4.04e-15	196	146	14	026a06d8d2089806823e6f6453d3ede84ae93bc6
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7 MEI1 IGHV3-64D IGHV3-74	4.94e-14	185	146	13	0fff2608f507e019ebb69c27e58fd5be3b049bef
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7 MEI1 IGHV3-64D IGHV3-74	4.94e-14	185	146	13	79edc1eeb7b5b9123961ac3ecf398ee68d9dddb9
ToppCell	5'-Adult-LargeIntestine-Hematopoietic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7 MEI1 IGHV3-74 IGHV3-72	7.46e-14	191	146	13	d1d30279ed4612b4f62c225d9eabf0b8a7a09d11
ToppCell	Biopsy_Other_PF-Immune-Plasma_cells\|Biopsy_Other_PF / Sample group, Lineage and Cell type	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-7 MEI1 RBMXL2 TLL2 IGHV3-72	9.75e-14	195	146	13	d0305c6a68c9e361507b04db94f86873085d49b3
ToppCell	Biopsy_IPF-Immune-Plasma_cells\|Biopsy_IPF / Sample group, Lineage and Cell type	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7 MEI1 IGHV3-74 IGHV3-72	1.04e-13	196	146	13	a1b6a8000b86efcb07843998aa3a49bb1f54bcda
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7 PRKCB IGHV3-74 IGHV3-72	1.11e-13	197	146	13	2662138671262b30508c5759038bcdcfe6551696
ToppCell	367C-Lymphocytic-Plasma_cell-\|367C / Donor, Lineage, Cell class and subclass (all cells)	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7 MEI1 IGHV3-72	3.67e-13	167	146	12	f2185eb72f0137136f6d71af2a70168fded6c940
ToppCell	367C-Lymphocytic-Plasma_cell\|367C / Donor, Lineage, Cell class and subclass (all cells)	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7 MEI1 IGHV3-72	3.67e-13	167	146	12	5e768cf24699893e05d1bcb1c92dba2336943a64
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7 MEI1 IGHV3-74	1.24e-12	185	146	12	08bc817908076734d66f2805cb954141f2cc5a18
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7 MEI1 IGHV3-74	1.24e-12	185	146	12	1704a12153a9b107bf03ecccd1a036cf61334d7a
ToppCell	COVID-19-Lymphoid-Plasma,_B_cells\|COVID-19 / Condition, Lineage and Cell class	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7 FEN1 PIP5K1B IGHV3-74	2.05e-12	193	146	12	bffd97a73365e1dd23ff3b0320b4860f04ec091a
ToppCell	COVID_non-vent-Lymphocytic-Plasma_cell-IgM_Plasmablast\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	IGHV3-48 IGHV3-43 IGHV3-38 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-9 IGHV3-7 HJURP IGHV3-74 IGHV3-72	2.05e-12	193	146	12	7b4b0271e4fbece703876acb053ae236afb7cdba
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7 IGHV3-74 IGHV3-72	2.05e-12	193	146	12	282b47dae6043eabb1e13d41d91c07b5ec21cd65
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7 MEI1 IGHV3-72	2.32e-12	195	146	12	13f4ee21568fd747608412d33559d10561dbb3c8
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7 MEI1 IGHV3-72	2.46e-12	196	146	12	c38e7f533c619afe008de0e99042f7180c2da918
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-48 IGHV3-43 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 MEI1 IGHV3-74	2.46e-12	196	146	12	fec21383435779bf4c632decd3d29c6ca7baebfb
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7 MEI1 IGHV3-74	1.38e-11	173	146	11	7e6bfe85f60834f317941b70d6e0dc3bd527d293
ToppCell	COPD-Lymphoid-B_Plasma\|World / Disease state, Lineage and Cell class	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-7 MEI1 IGHV3-64D	1.56e-11	175	146	11	d73ee324479172501481b54967a0f3bd870fcf3a
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	IGHV3-48 IGHV3-43 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-11 IGHV3-7 MEI1 IGHV3-74 IGHV3-72	1.76e-11	177	146	11	c2b0fb5921eea24d248d6e6ccb57c29b0832602c
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	IGHV3-48 IGHV3-43 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-11 IGHV3-7 MEI1 IGHV3-74 IGHV3-72	1.76e-11	177	146	11	111fb0707ff37ca631d85bb5a09e067ffe568eb8
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-7 MEI1 IGHV3-64D	2.25e-11	181	146	11	e47664a264a2c37390d1668ce04eef2e0172f4cb
ToppCell	cellseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-11 IGHV3-7 MEI1 IGHV3-74	2.53e-11	183	146	11	5ab4aa0304b832f98fff89b6c24ad5b7dd014c11
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-7 MEI1 IGHV3-74 IGHV3-72	5.02e-11	195	146	11	f3f7f1a77a1edd2b50a8211c76fe289738eb04cf
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-7 MEI1 IGHV3-72	5.02e-11	195	146	11	df009b18898c10686f75cf72b4ec0eff18f5bb50
ToppCell	COVID_non-vent-Lymphocytic-Plasma_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 HJURP IGHV3-74 IGHV3-72	5.60e-11	197	146	11	1e63879633f20646e44873ae6b662f6faf4806fd
ToppCell	healthy_donor-Lymphocytic-Plasma_cell-IgG_Plasmablast\|healthy_donor / Disease condition, Lineage, Cell class and subclass	IGHV3-43 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-9 IGHV3-7 ANKRD62 IGHV3-74 IGHV3-72	8.58e-11	152	146	10	a2ba2d95ac9010e1a62db34dcad10d004f8a90cc
ToppCell	BAL-Mild-Lymphocyte-B\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 IGHV3-64D	2.44e-10	169	146	10	307571e57c3bfdf15f0fe1a8b36585e8e4f8a207
ToppCell	Control-Lymphoid_P-Plasmablast\|Control / Disease group, lineage and cell class	IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-9 IGHV3-7 IGHV3-74	3.63e-10	176	146	10	4b4416f342b732d2cc60133838728880326257d8
ToppCell	Control-Lymphoid_P\|Control / Disease group, lineage and cell class	IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-9 IGHV3-7 IGHV3-74	3.63e-10	176	146	10	d895a6b295cd649273ff80ad7785a3e0ae4c728a
ToppCell	(2)_Plasma_cells\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-7 MEI1 IGHV3-72	3.84e-10	177	146	10	ed3c936bb69f9bc7291b4f6cde1d204078117c48
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-11 IGHV3-7 IGHV3-74	4.05e-10	178	146	10	107dae8b00c4257697a63700e72bb434cdb8406f
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-7 IGHV3-74 IGHV3-72	4.28e-10	179	146	10	837ed81f18257f444eaeadc4fac89deedd4e3061
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 IGHV3-72	4.28e-10	179	146	10	494febe77c6d4e6a2c6f0928bbf4c84b0301f188
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-7 IGHV3-74 IGHV3-72	4.28e-10	179	146	10	b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-15 IGHV3-11 IGHV3-7 MEI1 IGHV3-64D IGHV3-72	5.31e-10	183	146	10	cf5c98f451a568308c52da5c926543dd4836c6b2
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	KDM5A HJURP ANKRD62 ANKRD36C GPATCH2L CCNF BRD8 SLTM ANKRD11 ANKRD36	8.47e-10	192	146	10	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-48 IGHV3-43 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 PRKCB IGHV3-74	9.37e-10	194	146	10	a4a70369541876e1192df8828b63e3d1746ae3d9
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-48 IGHV3-43 IGHV3-38 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 MEI1 IGHV3-74	9.85e-10	195	146	10	2d18f08f33f3b261c77b8adf87d1a184cc6d7400
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-48 IGHV3-43 IGHV3-38 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15 IGHV3-11 MEI1 IGHV3-74	1.04e-09	196	146	10	b3d5540fe8ab9a9cbb9ab5350f5cb0e1aae93584
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7	1.09e-09	197	146	10	88b29d205237f07a9a26cc15a1cf4ed4816a4c4b
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_cell\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 PRKCB	1.09e-09	197	146	10	76465bb2408c7c75f694e8f7cf1a606b796afc3a
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	ATRX KDM5A RSF1 ANKRD62 DYNC2I1 ANKRD36C NSRP1 BRD9 SLTM ANKRD36	1.09e-09	197	146	10	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7	1.09e-09	197	146	10	9fe1b757f76c2d43d39aa9ac500eaba98723985c
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-7 IGHV3-74	7.49e-09	177	146	9	4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-7 IGHV3-74	7.49e-09	177	146	9	d746122bf8d208c3aa4d156e8c12d0a0e555c6e5
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-7 IGHV3-74	7.49e-09	177	146	9	fc40918825b7e1eb6861df59dfca944778a64b98
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-7 MEI1 IGHV3-74	9.10e-09	181	146	9	f7b08f662eb77ee7a777c6525ddc3195046aaf65
ToppCell	Mild_COVID-19-B_cell\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	1.00e-08	183	146	9	dea119e2988e954475f557f0bbe12556a83e81a4
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-48 IGHV3-43 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 MEI1	1.05e-08	184	146	9	15f2c10101ccc8ed059520fc082ee42593dff269
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-48 IGHV3-43 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 MEI1	1.05e-08	184	146	9	a90a58d9e319afa1cd572e4c2f516fadc42f56e5
ToppCell	COVID-19-Lymphoid-Plasma,_B_cells\|Lymphoid / Condition, Lineage and Cell class	IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7 PIP5K1B	1.45e-08	191	146	9	bcdadf83cb9653f9cc2a281e7c1095fe8f79173c
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_cell\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7	1.82e-08	196	146	9	e9fe5090452ffdde4bb81b62d57037d823281d00
ToppCell	Biopsy_Control_(H.)-Immune-Plasma_cells\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-7 MEI1	1.90e-08	197	146	9	275f38ed7e477000e864cecf9b7d49ae134c3b6a
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_cell-B_mature\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-48 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-7 PRKCB IGHV3-74 IGHV3-72	1.90e-08	197	146	9	da175e66d0a743a1b91d46f224b5ff1d37aa5410
ToppCell	Control-Control-Lymphocyte-B-Plasmablast\|Control / Disease, condition lineage and cell class	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-7 IGHV3-74	2.07e-08	199	146	9	c11aa8bca3723a886e7082ae48bb922dd8396be4
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_cell-B_naive\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-48 IGHV3-43 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-15 IGHV3-11 PRKCB CDCA7L	2.07e-08	199	146	9	8e02d3a066e79e0f2024a10738e0ea070513ef19
ToppCell	metastatic_Lymph_Node-B_lymphocytes-Plasma_cells\|metastatic_Lymph_Node / Location, Cell class and cell subclass	IGHV3-48 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-11 MEI1 TLL2	2.36e-08	142	146	8	5ba3a33c2ee20be8baaed97536ca6e9d1de6752f
ToppCell	368C-Lymphocytic-Plasma_cell-\|368C / Donor, Lineage, Cell class and subclass (all cells)	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-21 IGHV3-11 MEI1 IGHV3-74 IGHV3-72	6.57e-08	162	146	8	c21a54310b239d999bbc9d8fb5e8fda16e0bc336
ToppCell	368C-Lymphocytic-Plasma_cell\|368C / Donor, Lineage, Cell class and subclass (all cells)	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-21 IGHV3-11 MEI1 IGHV3-74 IGHV3-72	6.57e-08	162	146	8	f945688815229c8386cbcbf46deee7df316fa8d3
ToppCell	3'_v3-blood-Lymphocytic_B_plasma-Plasma_cells\|blood / Manually curated celltypes from each tissue	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-23 IGHV3-20 IGHV3-15 IGHV3-7 IGHV3-74	7.57e-08	165	146	8	1c0c24fe252b761cf879b83562e23c02f0b6489f
ToppCell	tumor_Lung-B_lymphocytes-Plasma_cells\|tumor_Lung / Location, Cell class and cell subclass	IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-15 IGHV3-11 IGHV3-7 MEI1 IGHV3-72	9.10e-08	169	146	8	b36b7632ce55fc7b6b8b66020563d360b3de6fd7
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell-B_activate-7\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-7 IGHV3-64D	9.53e-08	170	146	8	ee2ee67d90ae4596de8ccd620e37c82cf51651d4
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-7 IGHV3-64D	9.53e-08	170	146	8	d7ca0c6ce5d2b7de99346f87e07aa7fe728fa08a
ToppCell	BAL-Mild-Lymphocyte-B-B_cell\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-7 IGHV3-64D	9.53e-08	170	146	8	52787f6d529c285d9f0c04cc022710ead5b89b3f
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-48 IGHV3-43 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-7 MEI1 IGHV3-64D	1.09e-07	173	146	8	0ca2169a275404118038c0489a48062879488765
ToppCell	3'_v3-bone_marrow-Lymphocytic_B_plasma-Plasma_cells\|bone_marrow / Manually curated celltypes from each tissue	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-11 IGHV3-74	1.19e-07	175	146	8	51301f3f44d3e88397f367cedd1e2abaa2be4c6f
ToppCell	metastatic_Brain-B_lymphocytes-MALT_B_cells\|metastatic_Brain / Location, Cell class and cell subclass	IGHV3-48 IGHV3-43 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-7 MEI1	1.24e-07	176	146	8	50e207403d48ce1b55a78897adb5519a2430a626
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-1\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-9 IGHV3-7 NBPF10 CDCA7L	1.24e-07	176	146	8	ad05dd934f4ac2e656b3455de091f4c8772de6c8
ToppCell	VE-plasma\|VE / Condition, Cell_class and T cell subcluster	IGHV3-48 IGHV3-43 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	1.30e-07	177	146	8	0c1cc0834de55717cb4f69d020339060ce2c9a03
ToppCell	VE-plasma-\|VE / Condition, Cell_class and T cell subcluster	IGHV3-48 IGHV3-43 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7	1.30e-07	177	146	8	3a3c94cf30012e2aa266bc4d7fe772e45fa90f6d
ToppCell	5'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-Pre-B\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGHV3-33 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-11 IGHV3-7 IGHV3-64D PRKCB	1.36e-07	178	146	8	34ef4d36ddfb1cdeaaaf5d952e1ad6dc2785ce1e
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-43 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 IGHV3-11 IGHV3-7 MEI1	1.48e-07	180	146	8	cea079bc02e08c46600eed05ab9924ec90e1e3d3
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-11 IGHV3-72	1.48e-07	180	146	8	e3877f6ef5f54ff689058b4c996ab1851822f871
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-21 IGHV3-11 IGHV3-64D PRKCB MYBPC3	1.54e-07	181	146	8	e7d9910f6143055645b6f03b1018282e6c215f10
ToppCell	3'_v3-blood-Lymphocytic_B_plasma\|blood / Manually curated celltypes from each tissue	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-23 IGHV3-15 IGHV3-7 HJURP IGHV3-74	1.68e-07	183	146	8	2477183a290b2c45b6fa091ed76969a3826fe3d9
ToppCell	367C-Lymphocytic-Plasma_cell-\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7	1.75e-07	184	146	8	14a5288d861260f63fbe0cbea3569cf643e7597e
ToppCell	10x5'-Liver-Lymphocytic_B_plasma-Plasma_cells\|Liver / Manually curated celltypes from each tissue	IGHV3-48 IGHV3-30 IGHV3-23 IGHV3-15 IGHV3-7 IGHV3-64D IGHV3-74 IGHV3-72	1.75e-07	184	146	8	6f70d8f8ab8362d51f8a58735d42223e06566397
ToppCell	367C-Lymphocytic-Plasma_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-20 IGHV3-15 IGHV3-11 IGHV3-7	1.75e-07	184	146	8	fc708a5c8a7b19fab973c72dc4383a7d30f8b59a
ToppCell	BAL-Mild-Lymphocyte-B-B_cell\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-7 IGHV3-64D	1.82e-07	185	146	8	609080adb2cfb105bb7b8efb617553833299f371
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-15 IGHV3-7 MEI1 IGHV3-72	1.82e-07	185	146	8	6ec009e48e50471c28e914c402f500e56a88f8f2
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-15 IGHV3-7 MEI1 IGHV3-72	1.82e-07	185	146	8	f49ad6401b2abd089e30eba245b11b5031ea2318
ToppCell	healthy_donor-Lymphocytic-Plasma_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	IGHV3-48 IGHV3-38 IGHV3-33 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-7 IGHV3-74	2.06e-07	188	146	8	bd53b0371154cff680226897b61c9809a239d1b6
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-11 IGHV3-7 IGHV3-74 IGHV3-72	2.06e-07	188	146	8	6844cebca177fdf38b21a40d606230a033717a3a
ToppCell	cellseq2-Immune-Lymphocytic_B-Lymphocytic_B-Plasma\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-7 MEI1	2.06e-07	188	146	8	33360f1c30315d9772731c9067834dc059172b79
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	IGHV3-48 IGHV3-43 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-7 MEI1 IGHV3-72	2.15e-07	189	146	8	5a42be62552d912d0abf68f00d75ac80bbd69f2c
ToppCell	3'_v3-bone_marrow-Lymphocytic_B_plasma\|bone_marrow / Manually curated celltypes from each tissue	IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-7 IGHV3-74 IGHV3-72	2.15e-07	189	146	8	dceb011216deb4ffd830144a53c635c05dff5ec5
ToppCell	cellseq2-Immune-Lymphocytic_B-Lymphocytic_B\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-7 MEI1	2.33e-07	191	146	8	17746a32f723c078aba1f7e320b0e3f1ab8bf5c6
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic-B_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	IGHV3-33 IGHV3-23 IGHV3-21 IGHV3-7 WEE1 SETBP1 PRKCB IGHV3-74	2.33e-07	191	146	8	31169e01072e5fea364178264a35754b6cf2c93b
ToppCell	cellseq2-Immune-Lymphocytic_B\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-15 IGHV3-7 MEI1	2.33e-07	191	146	8	c2c450df810f83163987cd0f7ed9b50025cd3de1
ToppCell	BAL-Control-Lymphocyte-B-B_cell-B_cell-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-7 WEE1 SETBP1	2.52e-07	193	146	8	bcda1fb3db7d4c276e3370250a2b79fedd807fc5
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	IGHV3-48 IGHV3-43 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-20 MEI1	2.52e-07	193	146	8	5c5543e7c83ecea44d23521246592c0301044173
ToppCell	BAL-Control-Lymphocyte-B-B_cell-B_cell\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-7 WEE1 SETBP1	2.52e-07	193	146	8	befab58da635723db4f9270d087afa981fc45bf1
ToppCell	Control-B_cell-B_cell\|Control / Disease group,lineage and cell class （2021.01.30）	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-7 WEE1 SETBP1	2.52e-07	193	146	8	d43099c0b8ca68048d6497c4db89d6d5155375f9
ToppCell	BAL-Control-Lymphocyte-B-B_cell\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-7 WEE1 SETBP1	2.52e-07	193	146	8	ba826e6e035e48e1b497af1081c43339b0019e76
ToppCell	Control-Lymphoid-Plasma,_B_cells\|Control / Condition, Lineage and Cell class	IGHV3-48 IGHV3-33 IGHV3-30 IGHV3-23 IGHV3-21 IGHV3-7 WEE1 SETBP1	2.62e-07	194	146	8	31fff4361ebed6308b1e6b2b705ee6e0a695bd0c
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	GIN1 PPP1R12A HJURP MSL2 CCNF RIF1 TRIM32 CDYL MED13	8.06e-07	182	126	9	3887_DN
Drug	Succimer	ATRX KDM5A SRC AOX1 RSF1 EXOSC1 CWC22 FAM13B CEP170 RIF1 BRD8 NLRP10 PHF3 LUC7L2 SLTM PIP5K1B PRKCB UNC13A MED13 EPB41L2 ZNF445	5.84e-06	1264	126	21	ctd:D004113
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	PPP1R12A HJURP MSL2 CCNF RIF1 TRIM32 PHF3 CDYL	8.71e-06	184	126	8	2321_DN
Drug	Magnetite Nanoparticles	ATRX KDM5A SRC AOX1 RSF1 EXOSC1 CWC22 FAM13B CEP170 RIF1 BRD8 NLRP10 PHF3 LUC7L2 SLTM PIP5K1B PRKCB UNC13A MED13 EPB41L2 ZNF445	1.01e-05	1310	126	21	ctd:D058185
Drug	Doxorubicin hydrochloride [25316-40-9]; Down 200; 6.8uM; MCF7; HT_HG-U133A	WEE1 GIN1 HJURP MSL2 CCNF RIF1 TRIM32 PHF3	1.02e-05	188	126	8	3291_DN
Drug	Azacytidine-5 [320-67-2]; Down 200; 16.4uM; PC3; HT_HG-U133A	METTL3 WEE1 HJURP CCNF PHF3 FEN1 CDYL CLP1	1.10e-05	190	126	8	4010_DN
Drug	rofecoxib; Down 200; 10uM; MCF7; HG-U133A	ELOA BCL9 CCNF C2CD3 PHF3 MCM3AP POLR1B EPB41L2	1.48e-05	198	126	8	166_DN
Disease	fibroblast growth factor 8 isoform A measurement	IGHV3-7 IGHV3-64D	1.93e-05	2	130	2	EFO_0020385
Disease	tumor necrosis factor ligand superfamily member 11 measurement	IGHV3-21 IGHV3-11 IGHV3-7	2.31e-05	13	130	3	EFO_0010617
Disease	triacylglycerol 56:9 measurement	BCOR CCDC85A PRKCB	5.43e-05	17	130	3	EFO_0010436
Disease	dynein light chain 1, cytoplasmic measurement	IGHV3-7 IGHV3-64D	5.76e-05	3	130	2	EFO_0020339
Disease	stomach carcinoma (is_marker_for)	KDM5A MDC1 KDM4A	1.58e-04	24	130	3	DOID:5517 (is_marker_for)
Disease	alcohol use disorder (implicated_via_orthology)	DRD3 KDM5A RYR3 BRD9 PRKCB UNC13A	2.33e-04	195	130	6	DOID:1574 (implicated_via_orthology)
Disease	infection	RSF1 USP39	6.80e-04	9	130	2	EFO_0000544
Disease	lung cancer (is_marker_for)	ERCC5 KDM4A DNMT3B	6.80e-04	39	130	3	DOID:1324 (is_marker_for)
Disease	Neurodevelopmental Disorders	ASXL3 SCN1A SETBP1 ANKRD11	7.76e-04	93	130	4	C1535926
Disease	epilepsy (implicated_via_orthology)	KCNH7 SCN1A CDYL PRKG1 UNC13A	7.94e-04	163	130	5	DOID:1826 (implicated_via_orthology)
Disease	fish oil supplement exposure measurement, triglyceride measurement	MAP1A GJB6	8.47e-04	10	130	2	EFO_0004530, EFO_0600007
Disease	alopecia areata (is_marker_for)	KDM5A KDM4A	8.47e-04	10	130	2	DOID:986 (is_marker_for)
Disease	thrombin generation potential measurement	GJB6 MYBPC3	1.03e-03	11	130	2	EFO_0005538
Disease	Basal cell carcinoma	ERCC5 STAT5B	1.03e-03	11	130	2	C0007117
Disease	Saldino-Noonan Syndrome	DYNC2I1 C2CD3	1.69e-03	14	130	2	C0036069
Disease	mean platelet volume	KIF1B RSF1 DYNC2I1 PRC1 BCOR CWC22 DENND2B MPRIP BRD8 SETBP1 ANKRD11 MYBPC3	1.88e-03	1020	130	12	EFO_0004584
Disease	T-Cell Lymphoma	STAT5B ASXL3	2.22e-03	16	130	2	C0079772
Disease	APOE carrier status, dementia	RBMX HAND1 PRKG1	2.61e-03	62	130	3	EFO_0007659, MONDO_0001627
Disease	Febrile seizure (within the age range of 3 months to 6 years)	SCN1A HERC1	2.81e-03	18	130	2	HP_0002373
Disease	squamous cell carcinoma	SRC ANKRD11 CDYL	3.26e-03	67	130	3	EFO_0000707
Disease	Profound Mental Retardation	KDM5A SCN1A SETBP1 ARL14EP	3.39e-03	139	130	4	C0020796
Disease	Mental Retardation, Psychosocial	KDM5A SCN1A SETBP1 ARL14EP	3.39e-03	139	130	4	C0025363
Disease	Mental deficiency	KDM5A SCN1A SETBP1 ARL14EP	3.39e-03	139	130	4	C0917816
Disease	Intellectual Disability	PITRM1 KDM5A PPP1R12A SCN1A SETBP1 ARL14EP MED13	3.74e-03	447	130	7	C3714756

Protein segments in the cluster

Peptide	Gene	Start	Entry
SRVKQRFKRESDDFL	UNC13A	751	Q9UPW8
TSKGDRVAQSESKRR	CEP170	796	Q5SW79
FRVKSNTAIKGSDRR	EIF2D	6	P41214
KDISRSFREEKDRSN	ANKRD11	726	Q6UB99
ESRKYENKTRRRTAD	DNMT3B	371	Q9UBC3
LSGQRFKTRKRDEKE	BZW1	11	Q7L1Q6
RGRDSTRKQDASEKD	BRD8	831	Q9H0E9
GFKDERRNKVTFLSS	BRD9	371	Q9H8M2
EKRRLTKNATAGSDR	ARL14EP	171	Q8N8R7
GEFDRLARKTSNEKS	ANKRD62	351	A6NC57
RENKDGEKSRTVSSR	ANKRD36	806	A6QL64
QREAFRKSVASKSIR	DENND2B	1056	P78524
ENADGKVTVRRFRKR	BCOR	1386	Q6W2J9
ERLRQSGERFKKSIS	CAVIN4	246	Q5BKX8
GIRNESRDSEISKRK	ASXL3	951	Q9C0F0
AEKQSQRTRVFGSER	AOX1	226	Q06278
QNSGRTKFKRTSIDR	ATP8B2	276	P98198
RRISATAEDGNKFAK	FGF17	71	O60258
KGARRSQRSSKENFI	HJURP	311	Q8NCD3
KDKSRLFRVQFSGES	REC114	111	Q7Z4M0
SFREARSGIKEEKSR	NSRP1	201	Q9H0G5
RSGIKEEKSRGFSNE	NSRP1	206	Q9H0G5
KDRETNKSRGFAFVT	RBMX	41	P38159
FSNITREKKDGEISR	ANKRD36C	801	Q5JPF3
KGETVKRIREQSSAR	PCBP4	36	P57723
KGRFTISRDDSKNSL	IGHV3-72	86	A0A0B4J1Y9
SEKRAFPRKRDFTNE	MPRIP	336	Q6WCQ1
DSVKGRFTISRDNAK	IGHV3-11	81	P01762
DSVKGRFTISRDNSK	IGHV3-43D	81	P0DP04
DSVKGRFTISRDNSK	IGHV3-30-5	81	P0DP03
SSESGRVERLREKEK	MAP1A	2586	P78559
KASRIRAAEKVSRGD	MDC1	1016	Q14676
GKEKVRRSTSRDRLD	LYSMD3	46	Q7Z3D4
KGRFTISRDDSKNTL	IGHV3-15	86	A0A0B4J1V0
KEDQSRLGKESRREV	NLRP10	481	Q86W26
DSVKGRFTISRDNAK	IGHV3-7	81	P01780
DSVKGRFTISRDNSK	IGHV3-30-3	81	P0DP02
RRRKLSFESEGEKEN	KCNH7	891	Q9NS40
RKGRFTISRDNSKNT	IGHV3-38	81	A0A0C4DH36
RVRPFNSRETSKESK	KIF1B	11	O60333
DLRQAFRKFTKSERS	PRKG1	76	Q13976
DSVKGRFTISRDNAK	IGHV3-9	81	P01782
RKGRFTISRDNSKNT	IGHV3-38-3	81	P0DTE1
NERKEKTGARFSVRV	KIF26B	581	Q2KJY2
RIRRSSFSSKDEKRE	FAM13B	551	Q9NYF5
RVKRTDLDKARTFVG	MCM3AP	621	O60318
SSGETEKKDFRAALR	HERC1	1881	Q15751
KKRGERRNSFSENEK	CWC22	821	Q9HCG8
RAERKGRSVSKVRSE	DYNC2I1	156	Q8WVS4
SRTGEIQFSREFDKK	DSG4	441	Q86SJ6
RNGESRKEAFNRESK	DDX42	881	Q86XP3
RQKREKETSESRGIS	EPB41L2	61	O43491
DSVKGRFTISRDNAK	IGHV3-48	81	P01763
RSKRKVLGRRDSDDD	NHSL1	1366	Q5SYE7
EAERASRAKAEKQRS	MYH8	1126	P13535
SRAKAEKQRSDLSRE	MYH8	1131	P13535
NFEVKTRDESRSVGR	PLSCR3	221	Q9NRY6
EKSRERSRDVKNSEG	PDE9A	576	O76083
RRASRKEREKSNPTF	PIP5K1B	211	O14986
TRKKGSAARSFSERE	KDM4A	561	O75164
NKSRLPEFTESEKRR	LCT	1656	P09848
KNSFRGTIRKEDVRA	EXOSC1	96	Q9Y3B2
KKERRRTESINSAFA	HAND1	101	O96004
DSVKGRFTISRDNAK	IGHV3-20	81	A0A0C4DH32
DSVKGRFTISRDNSK	IGHV3-64D	81	A0A0J9YX35
TFRFQLKESDKDRRL	PRKCB	226	P05771
SRKKTVRRAFSEGQI	CDCA7L	251	Q96GN5
DSVKGRFTISRDNAK	IGHV3-74	81	A0A0B4J1X5
QRKGAERIFKTDSLT	HSFX3	121	A0A1B0GWH4
DSVKGRFTISRDNAK	IGHV3-21	81	A0A0B4J1V1
AKLNRKRSRSESDSE	MSL2	336	Q9HCI7
KRTRRVKTQSESGDV	KDM5A	216	P29375
DSVKGRFTISRDNSK	IGHV3-43	81	A0A0B4J1X8
QEKARASAETFRRAK	MFSD4B	211	Q5TF39
KEQSIVEKFRSRGRA	METTL3	256	Q86U44
SSRDSEKAILQRGKF	MEI1	486	Q5TIA1
REFKVTDARDGQSRT	PTPRS	1821	Q13332
SSREKEAKRNRTFVL	PROC	346	P04070
ETRKLFSELGSRNAK	FAM3A	161	P98173
VKGRNRRKVSSEDSE	ATRX	1366	P46100
SEDEQRPRTRSAKKA	ATRX	1396	P46100
FSEERIRSGVKRLSK	FEN1	316	P39748
FKEERQARRGVETSK	C2CD3	1771	Q4AC94
KRKRENSLQEDRGSF	CCNF	571	P41002
TGVTASKRKFIDDRR	CDYL	306	Q9Y232
DEQDFEKSNSRKRPR	ELOA	111	Q14241
KGKRERSISADSFDQ	BCL9	96	O00512
ETTRKFRRGEKRNDF	GJB6	101	O95452
RREEVQGVRKKFISS	DHX33	541	Q9H6R0
FLDDDRQKGKRVSRE	CCDC85A	111	Q96PX6
KREFLRRTEVDSKGN	DRC7	631	Q8IY82
ATKRSFSKEVEERSR	EIF4G1	1181	Q04637
DSVKGRFTISRDNSK	IGHV3-23	81	P01764
DSVKGRFTISRDNSK	IGHV3-30	81	P01768
DGQESRKRSSLFRKI	MAST2	1221	Q6P0Q8
AAKNLSRREGRETKT	ITGA10	231	O75578
ESAENRTFLSKTGRK	GPATCH2L	186	Q9NWQ4
ESKRSVRKRGRSTDE	RSF1	1266	Q96T23
NTTSVVDGDKRVKRR	SCUBE2	266	Q9NQ36
TRRAKENTFSKADAE	PEX1	181	O43933
ERGGELKREEKTRNS	DRD3	271	P35462
SSSDRSRKRELKEVF	PRPF3	81	O43395
GDTTRQRIKFSDDRV	LUC7L2	21	Q9Y383
DSVKGRFTISRDNSK	IGHV3-33	81	P01772
TRDKGIVDSERNAFK	RTN3	661	O95197
ESRTETDLSFKKGER	SRC	96	P12931
EEKRGSVSRGRSQEK	SRSF4	311	Q08170
RSRKFFTGSLAEVEK	TRIM32	201	Q13049
KDRETNKSRGFAFVT	RBMXL1	41	Q96E39
KRESRGSTRGKRESE	USP39	6	Q53GS9
KEKLREGRDASRSLN	NBPF10	381	Q6P3W6
DSEKIVNGTKRSSRR	RIF1	1276	Q5UIP0
SERSGIRRAAKKFVF	GIN1	31	Q9NXP7
IKEVRTGKNTDIFRS	PLCL2	191	Q9UPR0
RQAIKTAFRSKRDEA	ERCC5	116	P28715
TKASRREEFVSIKRQ	PRC1	166	O43663
VEDFLRSIGRSKKER	PITRM1	796	Q5JRX3
ADQAEARRSKTKEAR	RPL19	156	P84098
ERRDRFVGQSEGKKA	SLTM	791	Q9NWH9
RSDRRGAESVTEEKF	STAT5B	426	P51692
GKEAEKRFEALRATS	MED13	1156	Q9UHV7
KDRETNKSRGFAFVT	RBMXL2	41	O75526
DRKSASREKRSVVSF	SAFB	591	Q15424
QKSESEDSIRRKGFR	SCN1A	521	P35498
KSGGVVERSKDFRRE	CLP1	281	Q92989
KLEEGSFKERLARSR	TCEAL1	96	Q15170
KNRKRLDSRAEEGSV	TULP4	1336	Q9NRJ4
DTEKSGKREFDVRQT	WEE1	216	P30291
DLKRGKSRESVDSRD	THRAP3	731	Q9Y2W1
SLDGKNRRKLAERSE	UTP14C	51	Q5TAP6
SKDGREREREKRFSF	SPTBN2	2371	O15020
SGDDFFIGKVRRTRK	SRFBP1	281	Q8NEF9
DERTKKSNRDSLREA	RYR3	1026	Q15413
RERKRSGEAKEAASS	SCAF1	521	Q9H7N4
EKEKESIARARAGSR	STX12	126	Q86Y82
EGREKKGISDVRRTF	STARD3NL	41	O95772
FTGTTEAQKIRKDTR	SPATA31D1	1396	Q6ZQQ2
TGRFEEDFISKRRKG	SNX18	341	Q96RF0
KDRFSAERLKGVDST	TRBV11-2	81	A0A584
RVEFKSDNTVSKRGF	TLL2	711	Q9Y6L7
RSQDKDRDRKSREEG	PHF3	1951	Q92576
ASDKSRDRFSREQFK	TLNRD1	201	Q9H1K6
SEGRKTRRFKETNDK	IK	511	Q13123
KDRFSAERLKGVDST	TRBV11-3	81	A0A5A6
KDRFSAERLKGVDST	TRBV11-1	81	A0A0K0K1C0
SSRERGRLQTVKKEE	ZNF445	16	P59923
EKSTKAASEQRRAAR	WDR27	426	A2RRH5
VSDKFQVRTTGARDR	POLR1B	1006	Q9H9Y6
AKRQRKSRGSESEVL	SETBP1	1581	Q9Y6X0
KAVKQFEESRGRTSS	TG	2521	P01266
ESDASNFLKRRGKRS	UCMA	51	Q8WVF2
KRDSFRTPRDSKLEA	MYBPC3	301	Q14896
SRGITKENEREGEKR	PPP1R12A	811	O14974